Term	Accession	Genes (tot)	Stat (non-dir.) p	p adj (non-dir.)	Significant..in.gene.set.	Non.significant..in.gene.set.	Significant..not.in.gene.set.	Non.significant..not.in.gene.set.	effect.size
R-HSA-1059683	Interleukin-6 signaling	11	0.18343113336022	1	3	8	987	6215	1.9870523415978
R-HSA-109581	Apoptosis	73	0.419265939911694	1	11	62	979	6161	1.09786910197869
R-HSA-109606	Intrinsic Pathway for Apoptosis	18	0.226882351376564	1	4	14	986	6209	1.61907968574635
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	29	0.0369711937350509	0.886302875205662	8	21	982	6202	2.00989202368513
R-HSA-109703	PKB-mediated events	16	0.906029684851375	1	1	15	989	6208	0.455366161616162
R-HSA-109704	PI3K Cascade	33	0.682104894825802	1	4	29	986	6194	0.883134374043465
R-HSA-110056	MAPK3 (ERK1) activation	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-110312	Translesion synthesis by REV1	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	16	0.666260066302048	1	2	14	988	6209	0.910732323232323
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	12	0.830185993320943	1	1	11	989	6212	0.607154882154882
R-HSA-110320	Translesion Synthesis by POLH	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-111447	Activation of BAD and translocation to mitochondria 	11	0.458041388852471	1	2	9	988	6214	1.3247015610652
R-HSA-111465	Apoptotic cleavage of cellular proteins	18	0.930105734940293	1	1	17	989	6206	0.404769921436588
R-HSA-111885	Opioid Signalling	52	0.859490561135356	1	5	47	985	6176	0.700563325563326
R-HSA-111931	PKA-mediated phosphorylation of CREB	13	0.550031792606154	1	2	11	988	6212	1.12090132090132
R-HSA-111933	Calmodulin induced events	19	0.75699721466733	1	2	17	988	6206	0.766932482721956
R-HSA-111957	Cam-PDE 1 activation	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-111996	Ca-dependent events	21	0.804927980420863	1	2	19	988	6204	0.693891293891294
R-HSA-111997	CaM pathway	19	0.75699721466733	1	2	17	988	6206	0.766932482721956
R-HSA-112040	G-protein mediated events	32	0.835097684711842	1	3	29	987	6194	0.683049242424242
R-HSA-112043	PLC beta mediated events	31	0.818469073997265	1	3	28	987	6195	0.705083088954057
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-112310	Neurotransmitter Release Cycle	37	0.398490825618756	1	6	31	984	6192	1.18149058149058
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	79	0.999247743583311	1	3	76	987	6147	0.276678174146529
R-HSA-112382	Formation of RNA Pol II elongation complex 	22	0.0235739407354913	0.754871447281836	7	15	983	6208	2.3182277318641
R-HSA-112387	Elongation arrest and recovery	14	0.591720942589835	1	2	12	988	6211	1.04083694083694
R-HSA-112409	RAF-independent MAPK1/3 activation	15	0.630455364546741	1	2	13	988	6210	0.971447811447812
R-HSA-112411	MAPK1 (ERK2) activation	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-113418	Formation of the Early Elongation Complex	13	0.0239430591208336	0.754871447281836	5	8	985	6215	2.8022533022533
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	 5	0.141743208612563	1	2	3	988	6220	2.91434343434343
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	 5	1	1	0	5	990	6218	0
R-HSA-113510	E2F mediated regulation of DNA replication	13	0.550031792606154	1	2	11	988	6212	1.12090132090132
R-HSA-114452	Activation of BH3-only proteins	16	0.167154439514807	1	4	12	986	6211	1.82146464646465
R-HSA-114508	Effects of PIP2 hydrolysis	19	0.939722874955458	1	1	18	989	6205	0.383466241360978
R-HSA-114604	GPVI-mediated activation cascade	21	0.804927980420863	1	2	19	988	6204	0.693891293891294
R-HSA-114608	Platelet degranulation 	62	0.871094936403568	1	6	56	984	6167	0.705083088954057
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	89	0.233760720066391	1	15	74	975	6149	1.22795369424583
R-HSA-1169091	Activation of NF-kappaB in B cells	24	0.659050626853439	1	3	21	987	6202	0.910732323232323
R-HSA-1169408	ISG15 antiviral mechanism	38	0.424427737452551	1	6	32	984	6191	1.15039872408293
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	38	0.424427737452551	1	6	32	984	6191	1.15039872408293
R-HSA-1170546	Prolactin receptor signaling	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-1181150	Signaling by NODAL	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-1221632	Meiotic synapsis	23	0.0847403253454943	1	6	17	984	6206	1.90065876152833
R-HSA-1222556	ROS, RNS production in phagocytes	17	0.419144442349064	1	3	14	987	6209	1.28573975044563
R-HSA-1226099	Signaling by FGFR in disease	32	0.270266797223399	1	6	26	984	6197	1.36609848484848
R-HSA-1227986	Signaling by ERBB2	26	0.712856044668516	1	3	23	987	6200	0.840675990675991
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	 6	0.0373626381667968	0.886302875205662	3	3	987	6220	3.64292929292929
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	23	0.19972658405424	1	5	18	985	6205	1.58388230127361
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	19	0.494921626168357	1	3	16	987	6207	1.15039872408293
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	11	0.803122911123218	1	1	10	989	6213	0.662350780532599
R-HSA-1236394	Signaling by ERBB4	24	0.225840694854612	1	5	19	985	6204	1.51788720538721
R-HSA-1236974	ER-Phagosome pathway	36	0.889094220186433	1	3	33	987	6190	0.607154882154882
R-HSA-1236975	Antigen processing-Cross presentation	43	0.946784357937937	1	3	40	987	6183	0.508315715292459
R-HSA-1236977	Endosomal/Vacuolar pathway	 6	1	1	0	6	990	6217	0
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	15	0.630455364546741	1	2	13	988	6210	0.971447811447812
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	 8	1	1	0	8	990	6215	0
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	 5	1	1	0	5	990	6218	0
R-HSA-1250196	SHC1 events in ERBB2 signaling	15	0.630455364546741	1	2	13	988	6210	0.971447811447812
R-HSA-1250342	PI3K events in ERBB4 signaling	 7	0.247976182965643	1	2	5	988	6218	2.08167388167388
R-HSA-1250347	SHC1 events in ERBB4 signaling	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-1251985	Nuclear signaling by ERBB4	13	0.0239430591208336	0.754871447281836	5	8	985	6215	2.8022533022533
R-HSA-1257604	PIP3 activates AKT signaling	62	0.135083488673374	1	12	50	978	6173	1.41016617790811
R-HSA-1266695	Interleukin-7 signaling	 5	1	1	0	5	990	6218	0
R-HSA-1268020	Mitochondrial protein import	22	0.174729571291469	1	5	17	985	6206	1.6558769513315
R-HSA-1295596	Spry regulation of FGF signaling	 8	0.084760662074652	1	3	5	987	6218	2.73219696969697
R-HSA-1296041	Activation of G protein gated Potassium channels	13	1	1	0	13	990	6210	0
R-HSA-1296052	Ca2+ activated K+ channels	 6	1	1	0	6	990	6217	0
R-HSA-1296059	G protein gated Potassium channels	13	1	1	0	13	990	6210	0
R-HSA-1296065	Inwardly rectifying K+ channels	15	0.891044083692042	1	1	14	989	6209	0.485723905723906
R-HSA-1296071	Potassium Channels	45	0.989538666836819	1	2	43	988	6180	0.32381593714927
R-HSA-1296072	Voltage gated Potassium channels	19	0.939722874955458	1	1	18	989	6205	0.383466241360978
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-1368082	RORA activates gene expression	19	0.108198254496181	1	5	14	985	6209	1.91733120680489
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	30	0.605303300649356	1	4	26	986	6197	0.971447811447812
R-HSA-1369062	ABC transporters in lipid homeostasis	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-139853	Elevation of cytosolic Ca2+ levels	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-140342	Apoptosis induced DNA fragmentation	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-140534	Ligand-dependent caspase activation	 7	1	1	0	7	990	6216	0
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-140875	Common Pathway of Fibrin Clot Formation	 6	0.193933493835446	1	2	4	988	6219	2.42861952861953
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	14	0.591720942589835	1	2	12	988	6211	1.04083694083694
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	10	0.771751863644059	1	1	9	989	6214	0.728585858585859
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	10	0.771751863644059	1	1	9	989	6214	0.728585858585859
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	75	3.32204758648238e-06	0.00304285677734877	26	49	964	6174	2.52576430976431
R-HSA-1433559	Regulation of KIT signaling	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-1442490	Collagen degradation	25	0.6868182393475	1	3	22	987	6201	0.87430303030303
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	46	0.893291440576646	1	4	42	986	6181	0.633552920509442
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-1474228	Degradation of the extracellular matrix	49	0.972547006653748	1	3	46	987	6177	0.446072974644403
R-HSA-1474290	Collagen formation	38	0.785456064516767	1	4	34	986	6189	0.766932482721956
R-HSA-1475029	Reversible hydration of carbon dioxide	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-1480926	O2/CO2 exchange in erythrocytes	 8	1	1	0	8	990	6215	0
R-HSA-1482788	Acyl chain remodelling of PC	 8	1	1	0	8	990	6215	0
R-HSA-1482801	Acyl chain remodelling of PS	 8	1	1	0	8	990	6215	0
R-HSA-1482839	Acyl chain remodelling of PE	 9	1	1	0	9	990	6214	0
R-HSA-1482922	Acyl chain remodelling of PI	 6	1	1	0	6	990	6217	0
R-HSA-1482925	Acyl chain remodelling of PG	 6	1	1	0	6	990	6217	0
R-HSA-1483166	Synthesis of PA	12	0.830185993320943	1	1	11	989	6212	0.607154882154882
R-HSA-1483191	Synthesis of PC	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-1483206	Glycerophospholipid biosynthesis	51	0.561860597517737	1	7	44	983	6179	1.00001980590216
R-HSA-1483213	Synthesis of PE	 6	0.193933493835446	1	2	4	988	6219	2.42861952861953
R-HSA-1483249	Inositol phosphate metabolism	29	0.780921736141921	1	3	26	987	6197	0.753709508881923
R-HSA-1483255	PI Metabolism	41	0.680804074641511	1	5	36	985	6187	0.888519339738852
R-HSA-1483257	Phospholipid metabolism	91	0.721220642856101	1	11	80	979	6143	0.880708180708181
R-HSA-1489509	DAG and IP3 signaling	24	0.861096544079959	1	2	22	988	6201	0.607154882154882
R-HSA-1500620	Meiosis	31	0.122828381805384	1	7	24	983	6199	1.64519387422613
R-HSA-1500931	Cell-Cell communication	49	0.972547006653748	1	3	46	987	6177	0.446072974644403
R-HSA-1502540	Signaling by Activin	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-1538133	G0 and Early G1	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-156580	Phase II conjugation	28	0.176969343050637	1	6	22	984	6201	1.56125541125541
R-HSA-156584	Cytosolic sulfonation of small molecules	 6	1	1	0	6	990	6217	0
R-HSA-156590	Glutathione conjugation	17	0.0723669144512981	1	5	12	985	6211	2.14289958407605
R-HSA-1566948	Elastic fibre formation	18	1	1	0	18	990	6205	0
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	15	0.891044083692042	1	1	14	989	6209	0.485723905723906
R-HSA-156842	Eukaryotic Translation Elongation	 8	1	1	0	8	990	6215	0
R-HSA-156902	Peptide chain elongation	 7	1	1	0	7	990	6216	0
R-HSA-157118	Signaling by NOTCH	54	0.0121653170483078	0.624384689046346	14	40	976	6183	1.88892630003741
R-HSA-157579	Telomere Maintenance	21	0.5654184400452	1	3	18	987	6205	1.04083694083694
R-HSA-157858	Gap junction trafficking and regulation	22	0.82558867547774	1	2	20	988	6203	0.662350780532599
R-HSA-15869	Metabolism of nucleotides	41	0.833392045744915	1	4	37	986	6186	0.710815471791082
R-HSA-1592230	Mitochondrial biogenesis	30	0.605303300649356	1	4	26	986	6197	0.971447811447812
R-HSA-159227	Transport of the SLBP independent Mature mRNA	20	0.782117548004133	1	2	18	988	6205	0.728585858585859
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	20	0.782117548004133	1	2	18	988	6205	0.728585858585859
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	22	0.82558867547774	1	2	20	988	6203	0.662350780532599
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	22	0.82558867547774	1	2	20	988	6203	0.662350780532599
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	36	0.372494138794354	1	6	30	984	6193	1.21430976430976
R-HSA-1592389	Activation of Matrix Metalloproteinases	 8	1	1	0	8	990	6215	0
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	 8	1	1	0	8	990	6215	0
R-HSA-1614558	Degradation of cysteine and homocysteine	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-1614635	Sulfur amino acid metabolism	13	0.550031792606154	1	2	11	988	6212	1.12090132090132
R-HSA-162587	HIV Life Cycle	64	0.381534147647336	1	10	54	980	6169	1.1384154040404
R-HSA-162588	Budding and maturation of HIV virion	11	1	1	0	11	990	6212	0
R-HSA-162592	Integration of provirus	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-162594	Early Phase of HIV Life Cycle	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-162599	Late Phase of HIV Life Cycle	57	0.53125746384431	1	8	49	982	6174	1.02257664362928
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	 5	0.141743208612563	1	2	3	988	6220	2.91434343434343
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-162906	HIV Infection	98	0.366419189726114	1	15	83	975	6140	1.11518243661101
R-HSA-162909	Host Interactions of HIV factors	61	0.750434908886933	1	7	54	983	6169	0.836082132803444
R-HSA-1630316	Glycosaminoglycan metabolism	50	0.378827798807121	1	8	42	982	6181	1.16573737373737
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	31	0.989815674659639	1	1	30	989	6193	0.235027696318019
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	47	5.36186216272912e-06	0.00304285677734877	19	28	971	6195	2.94534708790028
R-HSA-163210	Formation of ATP by chemiosmotic coupling	 8	0.00188396951639017	0.213830540110285	5	3	985	6220	4.55366161616162
R-HSA-1632852	Macroautophagy	30	0.931547753062524	1	2	28	988	6195	0.485723905723906
R-HSA-163359	Glucagon signaling in metabolic regulation	17	0.699208816162447	1	2	15	988	6208	0.857159833630422
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	10	1	1	0	10	990	6213	0
R-HSA-163615	PKA activation	12	0.505429006948245	1	2	10	988	6213	1.21430976430976
R-HSA-163685	Integration of energy metabolism	58	0.401172977029068	1	9	49	981	6174	1.13056426332288
R-HSA-1638074	Keratan sulfate/keratin metabolism	11	0.18343113336022	1	3	8	987	6215	1.9870523415978
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	24	0.423015473847117	1	4	20	986	6203	1.21430976430976
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	 7	0.247976182965643	1	2	5	988	6218	2.08167388167388
R-HSA-1643713	Signaling by EGFR in Cancer	11	0.803122911123218	1	1	10	989	6213	0.662350780532599
R-HSA-164378	PKA activation in glucagon signalling	11	0.458041388852471	1	2	9	988	6214	1.3247015610652
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	12	1	1	0	12	990	6211	0
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	 5	1	1	0	5	990	6218	0
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	15	1	1	0	15	990	6208	0
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	21	0.804927980420863	1	2	19	988	6204	0.693891293891294
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	31	0.818469073997265	1	3	28	987	6195	0.705083088954057
R-HSA-165159	mTOR signalling	16	0.906029684851375	1	1	15	989	6208	0.455366161616162
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	38	0.0108247684106648	0.58784701232512	11	27	979	6196	2.10906432748538
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	63	0.240391462542028	1	11	52	979	6171	1.27213403880071
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	26	0.889867440491216	1	2	24	988	6199	0.56045066045066
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	 9	1	1	0	9	990	6214	0
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-166054	Activated TLR4 signalling	57	0.249938387482617	1	10	47	980	6176	1.27822080453659
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	52	0.167874092286133	1	10	42	980	6181	1.40112665112665
R-HSA-1660661	Sphingolipid de novo biosynthesis	23	0.966665025097961	1	1	22	989	6201	0.316776460254721
R-HSA-1660662	Glycosphingolipid metabolism	15	0.0442441512281394	0.887479435526579	5	10	985	6213	2.42861952861953
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade 	54	0.19904169308561	1	10	44	980	6179	1.34923307145529
R-HSA-166208	mTORC1-mediated signalling	 7	1	1	0	7	990	6216	0
R-HSA-166658	Complement cascade	15	1	1	0	15	990	6208	0
R-HSA-166663	Initial triggering of complement	 7	1	1	0	7	990	6216	0
R-HSA-166786	Creation of C4 and C2 activators	 5	1	1	0	5	990	6218	0
R-HSA-167021	PLC-gamma1 signalling	24	0.861096544079959	1	2	22	988	6201	0.607154882154882
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	16	0.0154787411708021	0.6757065857254	6	10	984	6213	2.73219696969697
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	13	0.0239430591208336	0.754871447281836	5	8	985	6215	2.8022533022533
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	11	0.0108764645452225	0.58784701232512	5	6	985	6217	3.31175390266299
R-HSA-167161	HIV Transcription Initiation	17	0.0723669144512981	1	5	12	985	6211	2.14289958407605
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	17	0.0723669144512981	1	5	12	985	6211	2.14289958407605
R-HSA-167169	HIV Transcription Elongation	15	0.0442441512281394	0.887479435526579	5	10	985	6213	2.42861952861953
R-HSA-167172	Transcription of the HIV genome	24	0.100492963012826	1	6	18	984	6205	1.82146464646465
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	15	0.0442441512281394	0.887479435526579	5	10	985	6213	2.42861952861953
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	 7	1	1	0	7	990	6216	0
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	 7	1	1	0	7	990	6216	0
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	 7	1	1	0	7	990	6216	0
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	15	0.0442441512281394	0.887479435526579	5	10	985	6213	2.42861952861953
R-HSA-167287	HIV elongation arrest and recovery	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-167290	Pausing and recovery of HIV elongation	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-167590	Nef Mediated CD4 Down-regulation	 7	1	1	0	7	990	6216	0
R-HSA-1679131	Trafficking and processing of endosomal TLR	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	55	0.124995948301452	1	11	44	979	6179	1.45717171717172
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	48	0.0567614940141887	0.967801477020447	11	37	979	6186	1.66967592592593
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	54	0.19904169308561	1	10	44	980	6179	1.34923307145529
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	48	0.0567614940141887	0.967801477020447	11	37	979	6186	1.66967592592593
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	52	0.167874092286133	1	10	42	980	6181	1.40112665112665
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	53	0.102167291404952	1	11	42	979	6181	1.51215932914046
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	52	0.167874092286133	1	10	42	980	6181	1.40112665112665
R-HSA-168253	Host Interactions with Influenza Factors	23	0.3901530106817	1	4	19	986	6204	1.26710584101888
R-HSA-168254	Influenza Infection	43	0.376309511335271	1	7	36	983	6187	1.18607000234907
R-HSA-168255	Influenza Life Cycle	39	0.450198473401003	1	6	33	984	6190	1.12090132090132
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	19	0.494921626168357	1	3	16	987	6207	1.15039872408293
R-HSA-168273	Influenza Viral RNA Transcription and Replication	31	0.818469073997265	1	3	28	987	6195	0.705083088954057
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	20	0.782117548004133	1	2	18	988	6205	0.728585858585859
R-HSA-168276	 NS1 Mediated Effects on Host Pathways	22	0.357035371268228	1	4	18	986	6205	1.3247015610652
R-HSA-168325	Viral Messenger RNA Synthesis	21	0.804927980420863	1	2	19	988	6204	0.693891293891294
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	19	0.75699721466733	1	2	17	988	6206	0.766932482721956
R-HSA-168638	NOD1/2 Signaling Pathway	15	0.630455364546741	1	2	13	988	6210	0.971447811447812
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	23	0.629546232727649	1	3	20	987	6203	0.950329380764163
R-HSA-168799	Neurotoxicity of clostridium toxins	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-168898	Toll-Like Receptors Cascades	76	0.151804121839872	1	14	62	976	6161	1.34213184476342
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	34	0.508597646936589	1	5	29	985	6194	1.07144979203803
R-HSA-169911	Regulation of Apoptosis	17	0.419144442349064	1	3	14	987	6209	1.28573975044563
R-HSA-170660	Adenylate cyclase activating pathway	 6	1	1	0	6	990	6217	0
R-HSA-170670	Adenylate cyclase inhibitory pathway	 8	1	1	0	8	990	6215	0
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	18	0.729410310614807	1	2	16	988	6207	0.809539842873176
R-HSA-170834	Signaling by TGF-beta Receptor Complex	42	0.112780481764211	1	9	33	981	6190	1.56125541125541
R-HSA-171007	p38MAPK events	 7	1	1	0	7	990	6216	0
R-HSA-171052	LDL-mediated lipid transport	10	0.771751863644059	1	1	9	989	6214	0.728585858585859
R-HSA-171306	Packaging Of Telomere Ends	12	0.830185993320943	1	1	11	989	6212	0.607154882154882
R-HSA-173623	Classical antibody-mediated complement activation	 5	1	1	0	5	990	6218	0
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	10	0.771751863644059	1	1	9	989	6214	0.728585858585859
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	23	0.629546232727649	1	3	20	987	6203	0.950329380764163
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	17	0.419144442349064	1	3	14	987	6209	1.28573975044563
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	28	0.548265735488286	1	4	24	986	6199	1.04083694083694
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	24	0.659050626853439	1	3	21	987	6202	0.910732323232323
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	24	0.659050626853439	1	3	21	987	6202	0.910732323232323
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	26	0.712856044668516	1	3	23	987	6200	0.840675990675991
R-HSA-174403	Glutathione synthesis and recycling	 7	0.0588267710099528	0.967801477020447	3	4	987	6219	3.12251082251082
R-HSA-174411	Polymerase switching on the C-strand of the telomere	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-174800	Chylomicron-mediated lipid transport	11	0.803122911123218	1	1	10	989	6213	0.662350780532599
R-HSA-174824	Lipoprotein metabolism	30	0.931547753062524	1	2	28	988	6195	0.485723905723906
R-HSA-176033	Interactions of Vpr with host cellular proteins	21	0.5654184400452	1	3	18	987	6205	1.04083694083694
R-HSA-176187	Activation of ATR in response to replication stress	15	0.339947199869943	1	3	12	987	6211	1.45717171717172
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	28	0.548265735488286	1	4	24	986	6199	1.04083694083694
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	26	0.712856044668516	1	3	23	987	6200	0.840675990675991
R-HSA-176412	Phosphorylation of the APC/C	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	26	0.712856044668516	1	3	23	987	6200	0.840675990675991
R-HSA-177243	Interactions of Rev with host cellular proteins	22	0.59832102985209	1	3	19	987	6204	0.993526170798898
R-HSA-177504	Retrograde neurotrophin signalling	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	20	0.128802719985544	1	5	15	985	6208	1.82146464646465
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	11	0.803122911123218	1	1	10	989	6213	0.662350780532599
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	26	0.712856044668516	1	3	23	987	6200	0.840675990675991
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	18	0.457596860543565	1	3	15	987	6208	1.21430976430976
R-HSA-180024	DARPP-32 events	20	0.290963624851114	1	4	16	986	6207	1.45717171717172
R-HSA-180292	GAB1 signalosome	63	0.147274714326721	1	12	51	978	6172	1.38778258778259
R-HSA-180534	Vpu mediated degradation of CD4	16	0.379822452259589	1	3	13	987	6210	1.36609848484848
R-HSA-180585	Vif-mediated degradation of APOBEC3G	17	0.699208816162447	1	2	15	988	6208	0.857159833630422
R-HSA-180746	Nuclear import of Rev protein	20	0.530914214636106	1	3	17	987	6206	1.09287878787879
R-HSA-180786	Extension of Telomeres	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-180910	Vpr-mediated nuclear import of PICs	20	0.782117548004133	1	2	18	988	6205	0.728585858585859
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	 8	1	1	0	8	990	6215	0
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	13	0.550031792606154	1	2	11	988	6212	1.12090132090132
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	13	0.550031792606154	1	2	11	988	6212	1.12090132090132
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	52	0.167874092286133	1	10	42	980	6181	1.40112665112665
R-HSA-182218	Nef Mediated CD8 Down-regulation	 6	1	1	0	6	990	6217	0
R-HSA-182971	EGFR downregulation	13	0.550031792606154	1	2	11	988	6212	1.12090132090132
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA 	30	0.221983430655768	1	6	24	984	6199	1.45717171717172
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	13	0.0910686735197566	1	4	9	986	6214	2.24180264180264
R-HSA-1839124	FGFR1 mutant receptor activation	19	0.108198254496181	1	5	14	985	6209	1.91733120680489
R-HSA-1839126	FGFR2 mutant receptor activation	10	1	1	0	10	990	6213	0
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	 6	1	1	0	6	990	6217	0
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	15	0.339947199869943	1	3	12	987	6211	1.45717171717172
R-HSA-186712	Regulation of beta-cell development	 7	0.247976182965643	1	2	5	988	6218	2.08167388167388
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	20	0.290963624851114	1	4	16	986	6207	1.45717171717172
R-HSA-189200	Hexose transport	23	0.629546232727649	1	3	20	987	6203	0.950329380764163
R-HSA-189445	Metabolism of porphyrins	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-189451	Heme biosynthesis	 7	0.247976182965643	1	2	5	988	6218	2.08167388167388
R-HSA-190236	Signaling by FGFR	40	0.475704440067052	1	6	34	984	6189	1.09287878787879
R-HSA-190241	FGFR2 ligand binding and activation	 5	1	1	0	5	990	6218	0
R-HSA-190242	FGFR1 ligand binding and activation	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-190373	FGFR1c ligand binding and activation	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-190828	Gap junction trafficking	21	0.804927980420863	1	2	19	988	6204	0.693891293891294
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	 8	1	1	0	8	990	6215	0
R-HSA-190861	Gap junction assembly	13	1	1	0	13	990	6210	0
R-HSA-190872	Transport of connexons to the plasma membrane	 9	1	1	0	9	990	6214	0
R-HSA-190873	Gap junction degradation	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-1912408	Pre-NOTCH Transcription and Translation	19	0.0100722135290709	0.58784701232512	7	12	983	6211	2.68426368952685
R-HSA-1912420	Pre-NOTCH Processing in Golgi	 7	0.0588267710099528	0.967801477020447	3	4	987	6219	3.12251082251082
R-HSA-1912422	Pre-NOTCH Expression and Processing	25	0.00432725442979232	0.377802598293406	9	16	981	6207	2.62290909090909
R-HSA-191273	Cholesterol biosynthesis	15	0.0442441512281394	0.887479435526579	5	10	985	6213	2.42861952861953
R-HSA-191859	snRNP Assembly	24	0.423015473847117	1	4	20	986	6203	1.21430976430976
R-HSA-192105	Synthesis of bile acids and bile salts	14	0.873671502415689	1	1	13	989	6210	0.52041847041847
R-HSA-192823	Viral mRNA Translation	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	 6	1	1	0	6	990	6217	0
R-HSA-193634	Axonal growth inhibition (RHOA activation)	 5	1	1	0	5	990	6218	0
R-HSA-193639	p75NTR signals via NF-kB	 7	1	1	0	7	990	6216	0
R-HSA-193648	NRAGE signals death through JNK	27	0.309000759721326	1	5	22	985	6201	1.34923307145529
R-HSA-193697	p75NTR regulates axonogenesis	 5	1	1	0	5	990	6218	0
R-HSA-193704	p75 NTR receptor-mediated signalling	44	0.573403992561009	1	6	38	984	6185	0.993526170798898
R-HSA-194068	Bile acid and bile salt metabolism	15	0.891044083692042	1	1	14	989	6209	0.485723905723906
R-HSA-194223	HDL-mediated lipid transport	 8	1	1	0	8	990	6215	0
R-HSA-194313	VEGF ligand-receptor interactions	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-194441	Metabolism of non-coding RNA	24	0.423015473847117	1	4	20	986	6203	1.21430976430976
R-HSA-194840	Rho GTPase cycle	64	0.523839913649818	1	9	55	981	6168	1.02457386363636
R-HSA-195253	Degradation of beta-catenin by the destruction complex	36	0.049899156138273	0.959924444354914	9	27	981	6196	1.82146464646465
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-196025	Formation of annular gap junctions	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-196071	Metabolism of steroid hormones	 7	0.247976182965643	1	2	5	988	6218	2.08167388167388
R-HSA-196299	Beta-catenin phosphorylation cascade	11	0.18343113336022	1	3	8	987	6215	1.9870523415978
R-HSA-1963640	GRB2 events in ERBB2 signaling	10	0.408112251490243	1	2	8	988	6215	1.45717171717172
R-HSA-1963642	PI3K events in ERBB2 signaling	11	0.458041388852471	1	2	9	988	6214	1.3247015610652
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	 8	1	1	0	8	990	6215	0
R-HSA-196757	Metabolism of folate and pterines	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-196780	Biotin transport and metabolism	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-196807	Nicotinate metabolism	13	1	1	0	13	990	6210	0
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	52	0.279418174288394	1	9	43	981	6180	1.26101398601399
R-HSA-196854	Metabolism of vitamins and cofactors	72	0.671007343857087	1	9	63	981	6160	0.910732323232323
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	11	0.18343113336022	1	3	8	987	6215	1.9870523415978
R-HSA-197264	Nicotinamide salvaging	 8	1	1	0	8	990	6215	0
R-HSA-1980143	Signaling by NOTCH1	35	0.0973116907513371	1	8	27	982	6196	1.66533910533911
R-HSA-1980145	Signaling by NOTCH2	15	0.339947199869943	1	3	12	987	6211	1.45717171717172
R-HSA-1980148	Signaling by NOTCH3	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-198203	PI3K/AKT activation	62	0.135083488673374	1	12	50	978	6173	1.41016617790811
R-HSA-198323	AKT phosphorylates targets in the cytosol	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-198693	AKT phosphorylates targets in the nucleus	 5	0.141743208612563	1	2	3	988	6220	2.91434343434343
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	20	0.128802719985544	1	5	15	985	6208	1.82146464646465
R-HSA-198753	ERK/MAPK targets	18	0.0893510134712082	1	5	13	985	6210	2.02384960718294
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	30	0.988187629756206	1	1	29	989	6194	0.242861952861953
R-HSA-1989781	PPARA activates gene expression	61	0.123466425325179	1	12	49	978	6174	1.43328365623448
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-199418	Negative regulation of the PI3K/AKT network	45	0.155582115370029	1	9	36	981	6187	1.45717171717172
R-HSA-199920	CREB phosphorylation	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-199977	ER to Golgi Anterograde Transport	66	0.958917148410659	1	5	61	985	6162	0.551958983777166
R-HSA-199992	trans-Golgi Network Vesicle Budding	41	0.982535818677347	1	2	39	988	6184	0.355407735895541
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	 6	1	1	0	6	990	6217	0
R-HSA-201451	Signaling by BMP	16	0.0154787411708021	0.6757065857254	6	10	984	6213	2.73219696969697
R-HSA-201681	TCF dependent signaling in response to WNT	82	0.147698703252014	1	15	67	975	6156	1.33277900960828
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	27	0.309000759721326	1	5	22	985	6201	1.34923307145529
R-HSA-202040	G-protein activation	11	1	1	0	11	990	6212	0
R-HSA-202131	Metabolism of nitric oxide	17	0.196319831842041	1	4	13	986	6210	1.71431966726084
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	25	0.6868182393475	1	3	22	987	6201	0.87430303030303
R-HSA-2022854	Keratan sulfate biosynthesis	11	0.18343113336022	1	3	8	987	6215	1.9870523415978
R-HSA-2022870	Chondroitin sulfate biosynthesis	10	0.147713523591521	1	3	7	987	6216	2.18575757575758
R-HSA-2022923	Dermatan sulfate biosynthesis	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-2022928	HS-GAG biosynthesis	14	1	1	0	14	990	6209	0
R-HSA-202403	TCR signaling	41	0.328990905333863	1	7	34	983	6189	1.24392707563439
R-HSA-2024096	HS-GAG degradation	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-2024101	CS/DS degradation	 6	0.0373626381667968	0.886302875205662	3	3	987	6220	3.64292929292929
R-HSA-202424	Downstream TCR signaling	34	0.320781793586961	1	6	28	984	6195	1.28573975044563
R-HSA-202433	Generation of second messenger molecules	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-202670	ERKs are inactivated	 9	0.114602333995133	1	3	6	987	6217	2.42861952861953
R-HSA-202733	Cell surface interactions at the vascular wall	63	1	1	0	63	990	6160	0
R-HSA-2028269	Signaling by Hippo	14	0.591720942589835	1	2	12	988	6211	1.04083694083694
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	47	0.640335112096148	1	6	41	984	6182	0.930109606705351
R-HSA-2029481	FCGR activation	 5	1	1	0	5	990	6218	0
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	29	0.199004539999459	1	6	23	984	6200	1.50741901776385
R-HSA-2029485	Role of phospholipids in phagocytosis	15	1	1	0	15	990	6208	0
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	18	0.226882351376564	1	4	14	986	6209	1.61907968574635
R-HSA-203615	eNOS activation	10	0.408112251490243	1	2	8	988	6215	1.45717171717172
R-HSA-203765	eNOS activation and regulation	17	0.196319831842041	1	4	13	986	6210	1.71431966726084
R-HSA-203927	MicroRNA (miRNA) biogenesis	12	0.505429006948245	1	2	10	988	6213	1.21430976430976
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	35	0.727127427775427	1	4	31	986	6192	0.832669552669553
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	12	0.221103298373598	1	3	9	987	6214	1.82146464646465
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-2046105	Linoleic acid (LA) metabolism	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	33	0.295310778769831	1	6	27	984	6196	1.3247015610652
R-HSA-205043	NRIF signals cell death from the nucleus	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-209543	p75NTR recruits signalling complexes	 6	1	1	0	6	990	6217	0
R-HSA-209560	NF-kB is activated and signals survival	 5	1	1	0	5	990	6218	0
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	22	0.59832102985209	1	3	19	987	6204	0.993526170798898
R-HSA-210745	Regulation of gene expression in beta cells	 6	0.193933493835446	1	2	4	988	6219	2.42861952861953
R-HSA-210990	PECAM1 interactions	 5	1	1	0	5	990	6218	0
R-HSA-210991	Basigin interactions	15	1	1	0	15	990	6208	0
R-HSA-210993	Tie2 Signaling	11	1	1	0	11	990	6212	0
R-HSA-211000	Gene Silencing by RNA	50	0.835080404490571	1	5	45	985	6178	0.728585858585859
R-HSA-211227	Activation of DNA fragmentation factor	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	15	0.630455364546741	1	2	13	988	6210	0.971447811447812
R-HSA-211859	Biological oxidations	59	0.286116031131888	1	10	49	980	6174	1.23489128573874
R-HSA-211897	Cytochrome P450 - arranged by substrate type	13	0.853532176713842	1	1	12	989	6211	0.56045066045066
R-HSA-211945	Phase 1 - Functionalization of compounds	30	0.605303300649356	1	4	26	986	6197	0.971447811447812
R-HSA-211976	Endogenous sterols	 7	1	1	0	7	990	6216	0
R-HSA-212165	Epigenetic regulation of gene expression	54	0.0588355082946351	0.967801477020447	12	42	978	6181	1.61907968574635
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	24	0.100492963012826	1	6	18	984	6205	1.82146464646465
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	12	0.505429006948245	1	2	10	988	6213	1.21430976430976
R-HSA-212300	PRC2 methylates histones and DNA	16	1	1	0	16	990	6207	0
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	16	0.666260066302048	1	2	14	988	6209	0.910732323232323
R-HSA-212718	EGFR interacts with phospholipase C-gamma	25	0.876251179274085	1	2	23	988	6200	0.582868686868687
R-HSA-2129379	Molecules associated with elastic fibres	17	1	1	0	17	990	6206	0
R-HSA-2132295	MHC class II antigen presentation	58	0.826222581334789	1	6	52	984	6171	0.753709508881923
R-HSA-2142753	Arachidonic acid metabolism	19	0.75699721466733	1	2	17	988	6206	0.766932482721956
R-HSA-2142845	Hyaluronan metabolism	 5	1	1	0	5	990	6218	0
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	24	0.423015473847117	1	4	20	986	6203	1.21430976430976
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	 7	1	1	0	7	990	6216	0
R-HSA-216083	Integrin cell surface interactions	39	0.996892967988282	1	1	38	989	6185	0.186816886816887
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	20	1	1	0	20	990	6203	0
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	16	0.666260066302048	1	2	14	988	6209	0.910732323232323
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	20	0.290963624851114	1	4	16	986	6207	1.45717171717172
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	 7	1	1	0	7	990	6216	0
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	26	0.0195171998360532	0.754871447281836	8	18	982	6205	2.24180264180264
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	15	0.339947199869943	1	3	12	987	6211	1.45717171717172
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	17	0.0212051532175341	0.754871447281836	6	11	984	6212	2.57147950089127
R-HSA-2179392	EGFR Transactivation by Gastrin	 5	1	1	0	5	990	6218	0
R-HSA-2187338	Visual phototransduction	36	0.96721463159428	1	2	34	988	6189	0.404769921436588
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	 7	0.247976182965643	1	2	5	988	6218	2.08167388167388
R-HSA-2214320	Anchoring fibril formation	 6	1	1	0	6	990	6217	0
R-HSA-2219528	PI3K/AKT Signaling in Cancer	41	0.192365767525405	1	8	33	982	6190	1.42163094358216
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	29	0.366598804441009	1	5	24	985	6199	1.2561825148032
R-HSA-2262749	Cellular response to hypoxia	23	0.19972658405424	1	5	18	985	6205	1.58388230127361
R-HSA-2299718	Condensation of Prophase Chromosomes	13	1	1	0	13	990	6210	0
R-HSA-2408517	SeMet incorporation into proteins	 6	0.193933493835446	1	2	4	988	6219	2.42861952861953
R-HSA-2408522	Selenoamino acid metabolism	17	0.699208816162447	1	2	15	988	6208	0.857159833630422
R-HSA-2408557	Selenocysteine synthesis	 8	1	1	0	8	990	6215	0
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	29	0.00382689648188572	0.361960625578358	10	19	980	6204	2.51236502960641
R-HSA-2428933	SHC-related events triggered by IGF1R	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-2453864	Retinoid cycle disease events	 5	1	1	0	5	990	6218	0
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	10	1	1	0	10	990	6213	0
R-HSA-2465910	MASTL Facilitates Mitotic Progression	 6	0.193933493835446	1	2	4	988	6219	2.42861952861953
R-HSA-2467813	Separation of Sister Chromatids	69	0.231403515418999	1	12	57	978	6166	1.26710584101888
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-2470946	Cohesin Loading onto Chromatin	 9	0.114602333995133	1	3	6	987	6217	2.42861952861953
R-HSA-2474795	Diseases associated with visual transduction	 5	1	1	0	5	990	6218	0
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	45	0.155582115370029	1	9	36	981	6187	1.45717171717172
R-HSA-2514856	The phototransduction cascade	11	0.458041388852471	1	2	9	988	6214	1.3247015610652
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	11	0.458041388852471	1	2	9	988	6214	1.3247015610652
R-HSA-2555396	Mitotic Metaphase and Anaphase	72	0.279341283570018	1	12	60	978	6163	1.21430976430976
R-HSA-2559580	Oxidative Stress Induced Senescence	45	0.883087369017262	1	4	41	986	6182	0.647631874298541
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	36	0.96721463159428	1	2	34	988	6189	0.404769921436588
R-HSA-2559583	Cellular Senescence	78	0.857361531775026	1	8	70	982	6153	0.747267547267547
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	 6	1	1	0	6	990	6217	0
R-HSA-2559585	Oncogene Induced Senescence	16	0.379822452259589	1	3	13	987	6210	1.36609848484848
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	22	0.961343040715922	1	1	21	989	6202	0.331175390266299
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	43	0.860113761498885	1	4	39	986	6184	0.677754287056613
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	31	0.24578064237986	1	6	25	984	6198	1.41016617790811
R-HSA-2644603	Signaling by NOTCH1 in Cancer	31	0.24578064237986	1	6	25	984	6198	1.41016617790811
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	31	0.24578064237986	1	6	25	984	6198	1.41016617790811
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	12	0.505429006948245	1	2	10	988	6213	1.21430976430976
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-264876	Insulin processing	24	0.659050626853439	1	3	21	987	6202	0.910732323232323
R-HSA-2672351	Stimuli-sensing channels	41	0.833392045744915	1	4	37	986	6186	0.710815471791082
R-HSA-2682334	EPH-Ephrin signaling	48	0.911378092909676	1	4	44	986	6179	0.607154882154882
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	 6	1	1	0	6	990	6217	0
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	 6	1	1	0	6	990	6217	0
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	68	0.216195058304619	1	12	56	978	6167	1.28573975044563
R-HSA-2871809	FCERI mediated Ca+2 mobilization	16	0.666260066302048	1	2	14	988	6209	0.910732323232323
R-HSA-2871837	FCERI mediated NF-kB activation	31	0.424318270893864	1	5	26	985	6197	1.17513848159009
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	31	0.24578064237986	1	6	25	984	6198	1.41016617790811
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	31	0.24578064237986	1	6	25	984	6198	1.41016617790811
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-2980736	Peptide hormone metabolism	40	0.658859105994449	1	5	35	985	6188	0.910732323232323
R-HSA-2980766	Nuclear Envelope Breakdown	25	0.876251179274085	1	2	23	988	6200	0.582868686868687
R-HSA-2990846	SUMOylation	48	0.661194335078105	1	6	42	984	6181	0.910732323232323
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-2995410	Nuclear Envelope Reassembly	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-3000157	Laminin interactions	14	1	1	0	14	990	6209	0
R-HSA-3000170	Syndecan interactions	19	1	1	0	19	990	6204	0
R-HSA-3000171	Non-integrin membrane-ECM interactions	31	0.939346282653231	1	2	29	988	6194	0.470055392636038
R-HSA-3000178	ECM proteoglycans	37	0.8998484303677	1	3	34	987	6189	0.590745290745291
R-HSA-3000480	Scavenging by Class A Receptors	12	1	1	0	12	990	6211	0
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	39	0.635964772753524	1	5	34	985	6189	0.934084434084434
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	47	0.640335112096148	1	6	41	984	6182	0.930109606705351
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production 	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-3214815	HDACs deacetylate histones	24	0.971254959055265	1	1	23	989	6200	0.303577441077441
R-HSA-3214841	PKMTs methylate histone lysines	20	0.290963624851114	1	4	16	986	6207	1.45717171717172
R-HSA-3214842	HDMs demethylate histones	11	0.458041388852471	1	2	9	988	6214	1.3247015610652
R-HSA-3214847	HATs acetylate histones	41	0.328990905333863	1	7	34	983	6189	1.24392707563439
R-HSA-3214858	RMTs methylate histone arginines	18	0.226882351376564	1	4	14	986	6209	1.61907968574635
R-HSA-3232118	SUMOylation of transcription factors	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-3247509	Chromatin modifying enzymes	98	0.117899564838778	1	18	80	972	6143	1.33821892393321
R-HSA-3295583	TRP channels	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-3296469	Defects in cobalamin (B12) metabolism	 5	1	1	0	5	990	6218	0
R-HSA-3296482	Defects in vitamin and cofactor metabolism	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-3299685	Detoxification of Reactive Oxygen Species	16	0.666260066302048	1	2	14	988	6209	0.910732323232323
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	20	0.782117548004133	1	2	18	988	6205	0.728585858585859
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	50	0.539769939116084	1	7	43	983	6180	1.0200202020202
R-HSA-3371511	HSF1 activation	20	0.782117548004133	1	2	18	988	6205	0.728585858585859
R-HSA-3371556	Cellular response to heat stress	63	0.362086841548637	1	10	53	980	6170	1.15648548981882
R-HSA-3371568	Attenuation phase	18	0.729410310614807	1	2	16	988	6207	0.809539842873176
R-HSA-3371571	HSF1-dependent transactivation	23	0.844259384311082	1	2	21	988	6202	0.633552920509442
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	17	0.699208816162447	1	2	15	988	6208	0.857159833630422
R-HSA-350054	Notch-HLH transcription pathway	 8	0.084760662074652	1	3	5	987	6218	2.73219696969697
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	18	0.729410310614807	1	2	16	988	6207	0.809539842873176
R-HSA-351202	Metabolism of polyamines	30	0.800434895641094	1	3	27	987	6196	0.728585858585859
R-HSA-352230	Amino acid transport across the plasma membrane	12	0.830185993320943	1	1	11	989	6212	0.607154882154882
R-HSA-354192	Integrin alphaIIb beta3 signaling	13	0.853532176713842	1	1	12	989	6211	0.56045066045066
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins 	 7	1	1	0	7	990	6216	0
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	13	0.26011368582975	1	3	10	987	6213	1.68135198135198
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-3595172	Defective CHST3 causes SEDCJD	 5	0.141743208612563	1	2	3	988	6220	2.91434343434343
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	 5	0.141743208612563	1	2	3	988	6220	2.91434343434343
R-HSA-3595177	Defective CHSY1 causes TPBS	 5	0.141743208612563	1	2	3	988	6220	2.91434343434343
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	 5	1	1	0	5	990	6218	0
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	 5	1	1	0	5	990	6218	0
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	 6	1	1	0	6	990	6217	0
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	77	0.985938628079472	1	5	72	985	6151	0.473107700380428
R-HSA-373080	Class B/2 (Secretin family receptors)	27	0.737189877849653	1	3	24	987	6199	0.809539842873176
R-HSA-373752	Netrin-1 signaling	23	0.3901530106817	1	4	19	986	6204	1.26710584101888
R-HSA-373753	Nephrin interactions	10	0.771751863644059	1	1	9	989	6214	0.728585858585859
R-HSA-373755	Semaphorin interactions	31	0.989815674659639	1	1	30	989	6193	0.235027696318019
R-HSA-373760	L1CAM interactions	66	0.562985643206064	1	9	57	981	6166	0.993526170798898
R-HSA-375170	CDO in myogenesis	14	0.873671502415689	1	1	13	989	6210	0.52041847041847
R-HSA-375276	Peptide ligand-binding receptors	45	0.957193534101013	1	3	42	987	6181	0.485723905723906
R-HSA-375280	Amine ligand-binding receptors	12	0.830185993320943	1	1	11	989	6212	0.607154882154882
R-HSA-376172	DSCAM interactions	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-376176	Signaling by Robo receptor	17	0.918955989144433	1	1	16	989	6207	0.428579916815211
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	18	0.226882351376564	1	4	14	986	6209	1.61907968574635
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	 6	1	1	0	6	990	6217	0
R-HSA-3781865	Diseases of glycosylation	25	0.11766746793203	1	6	19	984	6204	1.74860606060606
R-HSA-379716	Cytosolic tRNA aminoacylation	12	0.221103298373598	1	3	9	987	6214	1.82146464646465
R-HSA-379724	tRNA Aminoacylation	20	0.290963624851114	1	4	16	986	6207	1.45717171717172
R-HSA-379726	Mitochondrial tRNA aminoacylation	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-380108	Chemokine receptors bind chemokines	11	0.803122911123218	1	1	10	989	6213	0.662350780532599
R-HSA-380259	Loss of Nlp from mitotic centrosomes	36	0.889094220186433	1	3	33	987	6190	0.607154882154882
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	45	0.758855851410428	1	5	40	985	6183	0.809539842873176
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	36	0.889094220186433	1	3	33	987	6190	0.607154882154882
R-HSA-380287	Centrosome maturation	45	0.758855851410428	1	5	40	985	6183	0.809539842873176
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	14	0.591720942589835	1	2	12	988	6211	1.04083694083694
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	12	1	1	0	12	990	6211	0
R-HSA-380994	ATF4 activates genes	13	0.26011368582975	1	3	10	987	6213	1.68135198135198
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	 6	1	1	0	6	990	6217	0
R-HSA-381038	XBP1(S) activates chaperone genes	23	0.3901530106817	1	4	19	986	6204	1.26710584101888
R-HSA-381042	PERK regulates gene expression	15	0.339947199869943	1	3	12	987	6211	1.45717171717172
R-HSA-381070	IRE1alpha activates chaperones	23	0.3901530106817	1	4	19	986	6204	1.26710584101888
R-HSA-381119	Unfolded Protein Response (UPR)	41	0.328990905333863	1	7	34	983	6189	1.24392707563439
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	 5	1	1	0	5	990	6218	0
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	47	0.18791386766255	1	9	38	981	6185	1.39516441005803
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	 8	1	1	0	8	990	6215	0
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	24	0.659050626853439	1	3	21	987	6202	0.910732323232323
R-HSA-381753	Olfactory Signaling Pathway	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	 7	0.247976182965643	1	2	5	988	6218	2.08167388167388
R-HSA-382556	ABC-family proteins mediated transport	33	0.157568880264455	1	7	26	983	6197	1.54548515457606
R-HSA-383280	Nuclear Receptor transcription pathway	17	0.699208816162447	1	2	15	988	6208	0.857159833630422
R-HSA-3858494	Beta-catenin independent WNT signaling	67	0.309235259690907	1	11	56	979	6167	1.19618573797678
R-HSA-388841	Costimulation by the CD28 family	25	0.252884001585257	1	5	20	985	6203	1.45717171717172
R-HSA-389356	CD28 co-stimulation	14	0.591720942589835	1	2	12	988	6211	1.04083694083694
R-HSA-389357	CD28 dependent PI3K/Akt signaling	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-389513	CTLA4 inhibitory signaling	13	0.26011368582975	1	3	10	987	6213	1.68135198135198
R-HSA-389661	Glyoxylate metabolism and glycine degradation	11	0.18343113336022	1	3	8	987	6215	1.9870523415978
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	12	0.505429006948245	1	2	10	988	6213	1.21430976430976
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	12	0.505429006948245	1	2	10	988	6213	1.21430976430976
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	10	0.771751863644059	1	1	9	989	6214	0.728585858585859
R-HSA-389977	Post-chaperonin tubulin folding pathway	10	1	1	0	10	990	6213	0
R-HSA-390466	Chaperonin-mediated protein folding	39	0.635964772753524	1	5	34	985	6189	0.934084434084434
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	14	0.299896892704067	1	3	11	987	6212	1.56125541125541
R-HSA-390522	Striated Muscle Contraction	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	12	0.221103298373598	1	3	9	987	6214	1.82146464646465
R-HSA-390918	Peroxisomal lipid metabolism	 7	1	1	0	7	990	6216	0
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	 7	1	1	0	7	990	6216	0
R-HSA-391251	Protein folding	42	0.701781729341449	1	5	37	985	6186	0.867364117364117
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	16	1	1	0	16	990	6207	0
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	10	1	1	0	10	990	6213	0
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	17	0.918955989144433	1	1	16	989	6207	0.428579916815211
R-HSA-392517	Rap1 signalling	10	0.408112251490243	1	2	8	988	6215	1.45717171717172
R-HSA-392518	Signal amplification	15	1	1	0	15	990	6208	0
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-3928662	EPHB-mediated forward signaling	22	0.59832102985209	1	3	19	987	6204	0.993526170798898
R-HSA-3928663	EPHA-mediated growth cone collapse	16	1	1	0	16	990	6207	0
R-HSA-3928664	Ephrin signaling	 5	1	1	0	5	990	6218	0
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	26	0.889867440491216	1	2	24	988	6199	0.56045066045066
R-HSA-397795	G-protein beta:gamma signalling	18	0.729410310614807	1	2	16	988	6207	0.809539842873176
R-HSA-399719	Trafficking of AMPA receptors	21	1	1	0	21	990	6202	0
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	21	1	1	0	21	990	6202	0
R-HSA-399954	Sema3A PAK dependent Axon repulsion	 5	1	1	0	5	990	6218	0
R-HSA-399956	CRMPs in Sema3A signaling	 6	1	1	0	6	990	6217	0
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	14	1	1	0	14	990	6209	0
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	62	0.135083488673374	1	12	50	978	6173	1.41016617790811
R-HSA-400253	Circadian Clock	42	0.525569429861968	1	6	36	984	6187	1.04083694083694
R-HSA-400508	Incretin synthesis, secretion, and inactivation	 7	0.247976182965643	1	2	5	988	6218	2.08167388167388
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-400685	Sema4D in semaphorin signaling	13	1	1	0	13	990	6210	0
R-HSA-4085001	Sialic acid metabolism	13	0.853532176713842	1	1	12	989	6211	0.56045066045066
R-HSA-4086398	Ca2+ pathway	36	0.561913652843832	1	5	31	985	6192	1.01192480359147
R-HSA-4086400	PCP/CE pathway	34	0.320781793586961	1	6	28	984	6195	1.28573975044563
R-HSA-416476	G alpha (q) signalling events	64	0.99523008318237	1	3	61	987	6162	0.341524621212121
R-HSA-416482	G alpha (12/13) signalling events	41	0.833392045744915	1	4	37	986	6186	0.710815471791082
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	11	1	1	0	11	990	6212	0
R-HSA-416700	Other semaphorin interactions	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	11	1	1	0	11	990	6212	0
R-HSA-417957	P2Y receptors	 6	1	1	0	6	990	6217	0
R-HSA-418038	Nucleotide-like (purinergic) receptors	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-418217	G beta:gamma signalling through PLC beta	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-418346	Platelet homeostasis	51	0.847689802101875	1	5	46	985	6177	0.714299861358685
R-HSA-418359	Reduction of cytosolic Ca++ levels	11	0.803122911123218	1	1	10	989	6213	0.662350780532599
R-HSA-418360	Platelet calcium homeostasis	17	0.699208816162447	1	2	15	988	6208	0.857159833630422
R-HSA-418457	cGMP effects	11	1	1	0	11	990	6212	0
R-HSA-418555	G alpha (s) signalling events	51	0.978103656883083	1	3	48	987	6175	0.428579916815211
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	11	1	1	0	11	990	6212	0
R-HSA-418594	G alpha (i) signalling events	74	0.898130977847118	1	7	67	983	6156	0.689202839202839
R-HSA-418597	G alpha (z) signalling events	26	0.978627290255011	1	1	25	989	6198	0.28022533022533
R-HSA-418885	DCC mediated attractive signaling	 6	0.193933493835446	1	2	4	988	6219	2.42861952861953
R-HSA-418886	Netrin mediated repulsion signals	 6	1	1	0	6	990	6217	0
R-HSA-418889	Ligand-independent caspase activation via DCC	 5	1	1	0	5	990	6218	0
R-HSA-418990	Adherens junctions interactions	13	0.853532176713842	1	1	12	989	6211	0.56045066045066
R-HSA-419037	NCAM1 interactions	22	0.59832102985209	1	3	19	987	6204	0.993526170798898
R-HSA-419408	Lysosphingolipid and LPA receptors	 8	1	1	0	8	990	6215	0
R-HSA-419812	Calcitonin-like ligand receptors	 5	1	1	0	5	990	6218	0
R-HSA-420029	Tight junction interactions	 5	1	1	0	5	990	6218	0
R-HSA-420092	Glucagon-type ligand receptors	10	0.408112251490243	1	2	8	988	6215	1.45717171717172
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	 7	1	1	0	7	990	6216	0
R-HSA-421270	Cell-cell junction organization	18	0.930105734940293	1	1	17	989	6206	0.404769921436588
R-HSA-421837	Clathrin derived vesicle budding	41	0.982535818677347	1	2	39	988	6184	0.355407735895541
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-422356	Regulation of insulin secretion	44	0.400115480925913	1	7	37	983	6186	1.15911386593205
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	39	0.802540783575424	1	4	35	986	6188	0.747267547267547
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	47	0.47107915233864	1	7	40	983	6183	1.08512787448958
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	14	1	1	0	14	990	6209	0
R-HSA-425410	Metal ion SLC transporters	12	0.505429006948245	1	2	10	988	6213	1.21430976430976
R-HSA-425561	Sodium/Calcium exchangers	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-426496	Post-transcriptional silencing by small RNAs	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	14	0.591720942589835	1	2	12	988	6211	1.04083694083694
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	17	0.918955989144433	1	1	16	989	6207	0.428579916815211
R-HSA-427413	NoRC negatively regulates rRNA expression	33	0.0297230457662815	0.865016844736653	9	24	981	6199	1.9870523415978
R-HSA-428157	Sphingolipid metabolism	38	0.424427737452551	1	6	32	984	6191	1.15039872408293
R-HSA-428540	Activation of Rac	 6	1	1	0	6	990	6217	0
R-HSA-428790	Facilitative Na+-independent glucose transporters	 5	1	1	0	5	990	6218	0
R-HSA-428930	Thromboxane signalling through TP receptor	 9	1	1	0	9	990	6214	0
R-HSA-429914	Deadenylation-dependent mRNA decay	22	0.174729571291469	1	5	17	985	6206	1.6558769513315
R-HSA-429947	Deadenylation of mRNA	11	0.803122911123218	1	1	10	989	6213	0.662350780532599
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	 7	0.0588267710099528	0.967801477020447	3	4	987	6219	3.12251082251082
R-HSA-430116	GP1b-IX-V activation signalling	 6	1	1	0	6	990	6217	0
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	22	0.82558867547774	1	2	20	988	6203	0.662350780532599
R-HSA-432142	Platelet sensitization by LDL	11	0.458041388852471	1	2	9	988	6214	1.3247015610652
R-HSA-432720	Lysosome Vesicle Biogenesis	19	0.939722874955458	1	1	18	989	6205	0.383466241360978
R-HSA-432722	Golgi Associated Vesicle Biogenesis	34	0.957985657627971	1	2	32	988	6191	0.428579916815211
R-HSA-435354	Zinc transporters	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-437239	Recycling pathway of L1	29	0.57733244445585	1	4	25	986	6198	1.00494601184256
R-HSA-438064	Post NMDA receptor activation events	27	0.902081645502541	1	2	25	988	6198	0.539693228582117
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	14	1	1	0	14	990	6209	0
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	 6	0.193933493835446	1	2	4	988	6219	2.42861952861953
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	 5	1	1	0	5	990	6218	0
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	13	0.853532176713842	1	1	12	989	6211	0.56045066045066
R-HSA-442742	CREB phosphorylation through the activation of Ras	22	0.82558867547774	1	2	20	988	6203	0.662350780532599
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	31	0.939346282653231	1	2	29	988	6194	0.470055392636038
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	14	0.873671502415689	1	1	13	989	6210	0.52041847041847
R-HSA-444257	RSK activation	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-445095	Interaction between L1 and Ankyrins	18	0.930105734940293	1	1	17	989	6206	0.404769921436588
R-HSA-445144	Signal transduction by L1	11	0.18343113336022	1	3	8	987	6215	1.9870523415978
R-HSA-445355	Smooth Muscle Contraction	21	0.955172387750551	1	1	20	989	6203	0.346945646945647
R-HSA-445717	Aquaporin-mediated transport	23	0.844259384311082	1	2	21	988	6202	0.633552920509442
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	14	0.591720942589835	1	2	12	988	6211	1.04083694083694
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	29	0.922806895901095	1	2	27	988	6196	0.502473005921282
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	23	0.844259384311082	1	2	21	988	6202	0.633552920509442
R-HSA-446353	Cell-extracellular matrix interactions	 7	1	1	0	7	990	6216	0
R-HSA-446652	Interleukin-1 signaling	20	0.530914214636106	1	3	17	987	6206	1.09287878787879
R-HSA-446728	Cell junction organization	27	0.981571353514722	1	1	26	989	6197	0.269846614291059
R-HSA-447038	NrCAM interactions	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-447043	Neurofascin interactions	 5	0.141743208612563	1	2	3	988	6220	2.91434343434343
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	26	0.0559032842701729	0.967801477020447	7	19	983	6204	1.96157731157731
R-HSA-450294	MAP kinase activation in TLR cascade	40	0.0398937861969839	0.887479435526579	10	30	980	6193	1.82146464646465
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	10	0.0373428916035602	0.886302875205662	4	6	986	6217	2.91434343434343
R-HSA-450341	Activation of the AP-1 family of transcription factors	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	 8	0.084760662074652	1	3	5	987	6218	2.73219696969697
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	18	0.729410310614807	1	2	16	988	6207	0.809539842873176
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	 8	0.084760662074652	1	3	5	987	6218	2.73219696969697
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	34	0.320781793586961	1	6	28	984	6195	1.28573975044563
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-451306	Ionotropic activity of Kainate Receptors	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	15	0.630455364546741	1	2	13	988	6210	0.971447811447812
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	15	0.630455364546741	1	2	13	988	6210	0.971447811447812
R-HSA-453274	Mitotic G2-G2/M phases	78	0.382438756476631	1	12	66	978	6157	1.12090132090132
R-HSA-453276	Regulation of mitotic cell cycle	28	0.548265735488286	1	4	24	986	6199	1.04083694083694
R-HSA-453279	Mitotic G1-G1/S phases	48	0.33495095887632	1	8	40	982	6183	1.21430976430976
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	13	1	1	0	13	990	6210	0
R-HSA-4570464	SUMOylation of RNA binding proteins	25	0.876251179274085	1	2	23	988	6200	0.582868686868687
R-HSA-4608870	Asymmetric localization of PCP proteins	22	0.357035371268228	1	4	18	986	6205	1.3247015610652
R-HSA-4615885	SUMOylation of DNA replication proteins	22	0.82558867547774	1	2	20	988	6203	0.662350780532599
R-HSA-4641257	Degradation of AXIN	18	0.457596860543565	1	3	15	987	6208	1.21430976430976
R-HSA-4641258	Degradation of DVL	18	0.729410310614807	1	2	16	988	6207	0.809539842873176
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	15	0.339947199869943	1	3	12	987	6211	1.45717171717172
R-HSA-4641263	Regulation of FZD by ubiquitination	 8	1	1	0	8	990	6215	0
R-HSA-4641265	Repression of WNT target genes	 8	0.084760662074652	1	3	5	987	6218	2.73219696969697
R-HSA-4791275	Signaling by WNT in cancer	18	0.226882351376564	1	4	14	986	6209	1.61907968574635
R-HSA-4839726	Chromatin organization	98	0.117899564838778	1	18	80	972	6143	1.33821892393321
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	13	0.853532176713842	1	1	12	989	6211	0.56045066045066
R-HSA-500657	Presynaptic function of Kainate receptors	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	49	0.0126655646314596	0.624384689046346	13	36	977	6187	1.93298289012575
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-5099900	WNT5A-dependent internalization of FZD4	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-5173105	O-linked glycosylation	28	0.337703241606259	1	5	23	985	6200	1.30104617604618
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	10	0.408112251490243	1	2	8	988	6215	1.45717171717172
R-HSA-5205647	Mitophagy	13	0.853532176713842	1	1	12	989	6211	0.56045066045066
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	13	0.853532176713842	1	1	12	989	6211	0.56045066045066
R-HSA-5210891	Uptake and function of anthrax toxins	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-5213460	RIPK1-mediated regulated necrosis	 7	1	1	0	7	990	6216	0
R-HSA-5218859	Regulated Necrosis	 7	1	1	0	7	990	6216	0
R-HSA-5218920	VEGFR2 mediated vascular permeability	14	0.299896892704067	1	3	11	987	6212	1.56125541125541
R-HSA-5223345	Miscellaneous transport and binding events	11	0.458041388852471	1	2	9	988	6214	1.3247015610652
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	33	0.48097766850282	1	5	28	985	6195	1.10391796755433
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	27	0.518185379219424	1	4	23	986	6200	1.07938645716423
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	34	0.0132028480503192	0.624384689046346	10	24	980	6199	2.14289958407605
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-525793	Myogenesis	14	0.873671502415689	1	1	13	989	6210	0.52041847041847
R-HSA-5260271	Diseases of Immune System	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	16	0.167154439514807	1	4	12	986	6211	1.82146464646465
R-HSA-5334118	DNA methylation	12	1	1	0	12	990	6211	0
R-HSA-5336415	Uptake and function of diphtheria toxin	 5	1	1	0	5	990	6218	0
R-HSA-5339562	Uptake and actions of bacterial toxins	21	0.5654184400452	1	3	18	987	6205	1.04083694083694
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	12	1	1	0	12	990	6211	0
R-HSA-5357786	TNFR1-induced proapoptotic signaling	 6	0.193933493835446	1	2	4	988	6219	2.42861952861953
R-HSA-5357801	Programmed Cell Death	74	0.437840895003546	1	11	63	979	6160	1.08303303303303
R-HSA-5357905	Regulation of TNFR1 signaling	17	0.699208816162447	1	2	15	988	6208	0.857159833630422
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	15	0.339947199869943	1	3	12	987	6211	1.45717171717172
R-HSA-5358346	Hedgehog ligand biogenesis	22	0.357035371268228	1	4	18	986	6205	1.3247015610652
R-HSA-5358351	Signaling by Hedgehog	70	0.363690953168966	1	11	59	979	6164	1.14492063492063
R-HSA-5358508	Mismatch Repair	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-5362517	Signaling by Retinoic Acid	22	0.59832102985209	1	3	19	987	6204	0.993526170798898
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	18	0.226882351376564	1	4	14	986	6209	1.61907968574635
R-HSA-5365859	RA biosynthesis pathway	11	1	1	0	11	990	6212	0
R-HSA-5368286	Mitochondrial translation initiation	24	0.971254959055265	1	1	23	989	6200	0.303577441077441
R-HSA-5368287	Mitochondrial translation	28	0.759860774933017	1	3	25	987	6198	0.780627705627706
R-HSA-5387390	Hh mutants abrogate ligand secretion	18	0.226882351376564	1	4	14	986	6209	1.61907968574635
R-HSA-5389840	Mitochondrial translation elongation	25	0.876251179274085	1	2	23	988	6200	0.582868686868687
R-HSA-5419276	Mitochondrial translation termination	25	0.876251179274085	1	2	23	988	6200	0.582868686868687
R-HSA-5423646	Aflatoxin activation and detoxification	 5	0.141743208612563	1	2	3	988	6220	2.91434343434343
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-549132	Organic cation/anion/zwitterion transport	 6	1	1	0	6	990	6217	0
R-HSA-5576886	Phase 4 - resting membrane potential	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-5576891	Cardiac conduction	76	0.733383677802759	1	9	67	981	6156	0.862799043062201
R-HSA-5576892	Phase 0 - rapid depolarisation	25	0.6868182393475	1	3	22	987	6201	0.87430303030303
R-HSA-5576893	Phase 2 - plateau phase	12	0.505429006948245	1	2	10	988	6213	1.21430976430976
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	 6	0.193933493835446	1	2	4	988	6219	2.42861952861953
R-HSA-5578749	Transcriptional regulation by small RNAs	36	0.96721463159428	1	2	34	988	6189	0.404769921436588
R-HSA-5578775	Ion homeostasis	37	0.8998484303677	1	3	34	987	6189	0.590745290745291
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	 9	1	1	0	9	990	6214	0
R-HSA-5602358	Diseases associated with the TLR signaling cascade	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-5602498	MyD88 deficiency (TLR2/4)	 5	1	1	0	5	990	6218	0
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	 5	1	1	0	5	990	6218	0
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	22	0.59832102985209	1	3	19	987	6204	0.993526170798898
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	10	0.771751863644059	1	1	9	989	6214	0.728585858585859
R-HSA-5607764	CLEC7A (Dectin-1) signaling	44	0.573403992561009	1	6	38	984	6185	0.993526170798898
R-HSA-5610780	Degradation of GLI1 by the proteasome	19	0.258531443878	1	4	15	986	6208	1.53386496544391
R-HSA-5610783	Degradation of GLI2 by the proteasome	19	0.494921626168357	1	3	16	987	6207	1.15039872408293
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	20	0.530914214636106	1	3	17	987	6206	1.09287878787879
R-HSA-5610787	Hedgehog 'off' state	52	0.423004589789359	1	8	44	982	6179	1.12090132090132
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	35	0.535605387003627	1	5	30	985	6193	1.04083694083694
R-HSA-5619084	ABC transporter disorders	21	0.151031366196784	1	5	16	985	6207	1.73472823472823
R-HSA-5619115	Disorders of transmembrane transporters	22	0.174729571291469	1	5	17	985	6206	1.6558769513315
R-HSA-5619507	Activation of HOX genes during differentiation	35	0.535605387003627	1	5	30	985	6193	1.04083694083694
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	49	0.681281260046283	1	6	43	984	6180	0.892145949288806
R-HSA-5620916	VxPx cargo-targeting to cilium	14	0.591720942589835	1	2	12	988	6211	1.04083694083694
R-HSA-5620920	Cargo trafficking to the periciliary membrane	29	0.57733244445585	1	4	25	986	6198	1.00494601184256
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	13	0.550031792606154	1	2	11	988	6212	1.12090132090132
R-HSA-5620924	Intraflagellar transport	32	0.946296189182657	1	2	30	988	6193	0.455366161616162
R-HSA-5621481	C-type lectin receptors (CLRs)	56	0.51009606629943	1	8	48	982	6175	1.04083694083694
R-HSA-5621575	CD209 (DC-SIGN) signaling	10	0.408112251490243	1	2	8	988	6215	1.45717171717172
R-HSA-5625740	RHO GTPases activate PKNs	29	0.922806895901095	1	2	27	988	6196	0.502473005921282
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	14	1	1	0	14	990	6209	0
R-HSA-5625900	RHO GTPases activate CIT	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-5625970	RHO GTPases activate KTN1	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-5626467	RHO GTPases activate IQGAPs	15	0.891044083692042	1	1	14	989	6209	0.485723905723906
R-HSA-5627117	RHO GTPases Activate ROCKs	 8	1	1	0	8	990	6215	0
R-HSA-5627123	RHO GTPases activate PAKs	12	0.830185993320943	1	1	11	989	6212	0.607154882154882
R-HSA-5628897	TP53 Regulates Metabolic Genes	46	0.090579522421342	1	10	36	980	6187	1.58388230127361
R-HSA-5632684	Hedgehog 'on' state	32	0.452846321573579	1	5	27	985	6196	1.1384154040404
R-HSA-5633007	Regulation of TP53 Activity	70	0.247019462519873	1	12	58	978	6165	1.24900432900433
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	22	0.59832102985209	1	3	19	987	6204	0.993526170798898
R-HSA-5635838	Activation of SMO	 7	1	1	0	7	990	6216	0
R-HSA-5637810	Constitutive Signaling by EGFRvIII	10	0.771751863644059	1	1	9	989	6214	0.728585858585859
R-HSA-5637812	Signaling by EGFRvIII in Cancer	10	0.771751863644059	1	1	9	989	6214	0.728585858585859
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	11	0.803122911123218	1	1	10	989	6213	0.662350780532599
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-5654687	Downstream signaling of activated FGFR1	15	0.630455364546741	1	2	13	988	6210	0.971447811447812
R-HSA-5654688	SHC-mediated cascade:FGFR1	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-5654689	PI-3K cascade:FGFR1	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-5654693	FRS-mediated FGFR1 signaling	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-5654695	PI-3K cascade:FGFR2	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-5654696	Downstream signaling of activated FGFR2	13	0.853532176713842	1	1	12	989	6211	0.56045066045066
R-HSA-5654699	SHC-mediated cascade:FGFR2	 8	1	1	0	8	990	6215	0
R-HSA-5654700	FRS-mediated FGFR2 signaling	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-5654704	SHC-mediated cascade:FGFR3	 8	1	1	0	8	990	6215	0
R-HSA-5654706	FRS-mediated FGFR3 signaling	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-5654708	Downstream signaling of activated FGFR3	13	0.853532176713842	1	1	12	989	6211	0.56045066045066
R-HSA-5654710	PI-3K cascade:FGFR3	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-5654712	FRS-mediated FGFR4 signaling	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-5654716	Downstream signaling of activated FGFR4	12	0.830185993320943	1	1	11	989	6212	0.607154882154882
R-HSA-5654719	SHC-mediated cascade:FGFR4	 7	1	1	0	7	990	6216	0
R-HSA-5654720	PI-3K cascade:FGFR4	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-5654726	Negative regulation of FGFR1 signaling	14	0.0331355390926861	0.886302875205662	5	9	985	6214	2.60209235209235
R-HSA-5654727	Negative regulation of FGFR2 signaling	13	0.0910686735197566	1	4	9	986	6214	2.24180264180264
R-HSA-5654732	Negative regulation of FGFR3 signaling	13	0.0910686735197566	1	4	9	986	6214	2.24180264180264
R-HSA-5654733	Negative regulation of FGFR4 signaling	12	0.070414638320088	1	4	8	986	6215	2.42861952861953
R-HSA-5654736	Signaling by FGFR1	25	0.11766746793203	1	6	19	984	6204	1.74860606060606
R-HSA-5654738	Signaling by FGFR2	33	0.682104894825802	1	4	29	986	6194	0.883134374043465
R-HSA-5654741	Signaling by FGFR3	20	0.290963624851114	1	4	16	986	6207	1.45717171717172
R-HSA-5654743	Signaling by FGFR4	19	0.258531443878	1	4	15	986	6208	1.53386496544391
R-HSA-5655253	Signaling by FGFR2 in disease	17	0.918955989144433	1	1	16	989	6207	0.428579916815211
R-HSA-5655291	Signaling by FGFR4 in disease	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-5655302	Signaling by FGFR1 in disease	24	0.100492963012826	1	6	18	984	6205	1.82146464646465
R-HSA-5655332	Signaling by FGFR3 in disease	11	0.803122911123218	1	1	10	989	6213	0.662350780532599
R-HSA-5655862	Translesion synthesis by POLK	10	0.771751863644059	1	1	9	989	6214	0.728585858585859
R-HSA-5656121	Translesion synthesis by POLI	10	0.771751863644059	1	1	9	989	6214	0.728585858585859
R-HSA-5656169	Termination of translesion DNA synthesis	13	0.853532176713842	1	1	12	989	6211	0.56045066045066
R-HSA-5658442	Regulation of RAS by GAPs	27	0.155996766785416	1	6	21	984	6202	1.61907968574635
R-HSA-5660526	Response to metal ions	 7	1	1	0	7	990	6216	0
R-HSA-5661231	Metallothioneins bind metals	 7	1	1	0	7	990	6216	0
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	19	0.258531443878	1	4	15	986	6208	1.53386496544391
R-HSA-5663220	RHO GTPases Activate Formins	50	0.378827798807121	1	8	42	982	6181	1.16573737373737
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	 5	1	1	0	5	990	6218	0
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	29	0.780921736141921	1	3	26	987	6197	0.753709508881923
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	 5	1	1	0	5	990	6218	0
R-HSA-5668914	Diseases of metabolism	11	0.458041388852471	1	2	9	988	6214	1.3247015610652
R-HSA-5673000	RAF activation	14	0.299896892704067	1	3	11	987	6212	1.56125541125541
R-HSA-5674135	MAP2K and MAPK activation	22	1	1	0	22	990	6201	0
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	12	0.221103298373598	1	3	9	987	6214	1.82146464646465
R-HSA-5675221	Negative regulation of MAPK pathway	22	0.357035371268228	1	4	18	986	6205	1.3247015610652
R-HSA-5675482	Regulation of necroptotic cell death	 6	1	1	0	6	990	6217	0
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	22	0.59832102985209	1	3	19	987	6204	0.993526170798898
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	 5	1	1	0	5	990	6218	0
R-HSA-5678895	Defective CFTR causes cystic fibrosis	20	0.290963624851114	1	4	16	986	6207	1.45717171717172
R-HSA-5682910	LGI-ADAM interactions	10	1	1	0	10	990	6213	0
R-HSA-5683826	Surfactant metabolism	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	16	0.379822452259589	1	3	13	987	6210	1.36609848484848
R-HSA-5685942	HDR through Homologous Recombination (HRR)	19	0.258531443878	1	4	15	986	6208	1.53386496544391
R-HSA-5686938	Regulation of TLR by endogenous ligand	 8	1	1	0	8	990	6215	0
R-HSA-5687128	MAPK6/MAPK4 signaling	40	0.658859105994449	1	5	35	985	6188	0.910732323232323
R-HSA-5689603	UCH proteinases	33	0.157568880264455	1	7	26	983	6197	1.54548515457606
R-HSA-5689877	Josephin domain DUBs	 5	0.141743208612563	1	2	3	988	6220	2.91434343434343
R-HSA-5689880	Ub-specific processing proteases	79	0.658681079252524	1	10	69	980	6154	0.922260580488429
R-HSA-5689896	Ovarian tumor domain proteases	14	0.299896892704067	1	3	11	987	6212	1.56125541125541
R-HSA-5689901	Metalloprotease DUBs	11	0.458041388852471	1	2	9	988	6214	1.3247015610652
R-HSA-5693532	DNA Double-Strand Break Repair	54	0.319121767139247	1	9	45	981	6178	1.21430976430976
R-HSA-5693537	Resolution of D-Loop Structures	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-5693538	Homology Directed Repair	44	0.573403992561009	1	6	38	984	6185	0.993526170798898
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	26	0.712856044668516	1	3	23	987	6200	0.840675990675991
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	42	0.701781729341449	1	5	37	985	6186	0.867364117364117
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	24	0.861096544079959	1	2	22	988	6201	0.607154882154882
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	14	0.114241927290585	1	4	10	986	6213	2.08167388167388
R-HSA-5693606	DNA Double Strand Break Response	26	0.712856044668516	1	3	23	987	6200	0.840675990675991
R-HSA-5693607	Processing of DNA double-strand break ends	34	0.705239194544364	1	4	30	986	6193	0.857159833630422
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	14	0.114241927290585	1	4	10	986	6213	2.08167388167388
R-HSA-5694530	Cargo concentration in the ER	16	0.906029684851375	1	1	15	989	6208	0.455366161616162
R-HSA-5696394	DNA Damage Recognition in GG-NER	16	0.379822452259589	1	3	13	987	6210	1.36609848484848
R-HSA-5696395	Formation of Incision Complex in GG-NER	27	0.155996766785416	1	6	21	984	6202	1.61907968574635
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	10	0.771751863644059	1	1	9	989	6214	0.728585858585859
R-HSA-5696398	Nucleotide Excision Repair	53	0.102167291404952	1	11	42	979	6181	1.51215932914046
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	44	0.0707216390473742	1	10	34	980	6189	1.6558769513315
R-HSA-5696400	Dual Incision in GG-NER	21	0.151031366196784	1	5	16	985	6207	1.73472823472823
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	15	0.630455364546741	1	2	13	988	6210	0.971447811447812
R-HSA-611105	Respiratory electron transport	36	0.000613519625681256	0.0913215559913932	13	23	977	6200	2.63100448933782
R-HSA-622312	Inflammasomes	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-674695	RNA Polymerase II Pre-transcription Events	29	0.0925010880801512	1	7	22	983	6201	1.75865552072449
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	25	0.0461070307686792	0.902266895214671	7	18	983	6205	2.0400404040404
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	37	0.125373495374928	1	8	29	982	6194	1.57532077532078
R-HSA-6782135	Dual incision in TC-NER	30	0.107088977374221	1	7	23	983	6200	1.70003367003367
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	27	0.0668965698886853	1	7	20	983	6203	1.88892630003741
R-HSA-6782315	tRNA modification in the nucleus and cytosol	15	0.000321787835896494	0.0749987459961466	8	7	982	6216	3.88579124579125
R-HSA-6783310	Fanconi Anemia Pathway	11	0.458041388852471	1	2	9	988	6214	1.3247015610652
R-HSA-6783589	Interleukin-6 family signaling	17	0.419144442349064	1	3	14	987	6209	1.28573975044563
R-HSA-6783783	Interleukin-10 signaling	18	1	1	0	18	990	6205	0
R-HSA-6784531	tRNA processing in the nucleus	29	0.922806895901095	1	2	27	988	6196	0.502473005921282
R-HSA-6785631	ERBB2 Regulates Cell Motility	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-6785807	Interleukin-4 and 13 signaling	51	0.847689802101875	1	5	46	985	6177	0.714299861358685
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	10	1	1	0	10	990	6213	0
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	19	0.75699721466733	1	2	17	988	6206	0.766932482721956
R-HSA-6790901	rRNA modification in the nucleus and cytosol	15	1	1	0	15	990	6208	0
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	33	0.952483235987961	1	2	31	988	6192	0.441567187021733
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	20	0.128802719985544	1	5	15	985	6208	1.82146464646465
R-HSA-6794361	Interactions of neurexins and neuroligins at synapses	35	0.994373783723433	1	1	34	989	6189	0.208167388167388
R-HSA-6794362	Protein-protein interactions at synapses	41	0.997691381072029	1	1	40	989	6183	0.17770386794777
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	24	0.00071496568128427	0.0913215559913932	10	14	980	6209	3.03577441077441
R-HSA-6799198	Complex I biogenesis	17	0.0212051532175341	0.754871447281836	6	11	984	6212	2.57147950089127
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	22	0.961343040715922	1	1	21	989	6202	0.331175390266299
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	20	1	1	0	20	990	6203	0
R-HSA-6802949	Signaling by RAS mutants	29	0.57733244445585	1	4	25	986	6198	1.00494601184256
R-HSA-6802952	Signaling by BRAF and RAF fusions	31	0.939346282653231	1	2	29	988	6194	0.470055392636038
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	22	0.961343040715922	1	1	21	989	6202	0.331175390266299
R-HSA-6802957	Oncogenic MAPK signaling	39	0.450198473401003	1	6	33	984	6190	1.12090132090132
R-HSA-6803157	Antimicrobial peptides	14	0.873671502415689	1	1	13	989	6210	0.52041847041847
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	 6	1	1	0	6	990	6217	0
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	 6	1	1	0	6	990	6217	0
R-HSA-6803529	FGFR2 alternative splicing	13	1	1	0	13	990	6210	0
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	 7	0.0588267710099528	0.967801477020447	3	4	987	6219	3.12251082251082
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	10	0.408112251490243	1	2	8	988	6215	1.45717171717172
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	38	0.612148580528842	1	5	33	985	6190	0.958665603402446
R-HSA-6804757	Regulation of TP53 Degradation	17	0.196319831842041	1	4	13	986	6210	1.71431966726084
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	14	0.591720942589835	1	2	12	988	6211	1.04083694083694
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-6804760	Regulation of TP53 Activity through Methylation	 9	0.114602333995133	1	3	6	987	6217	2.42861952861953
R-HSA-6805567	Keratinization	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-6806003	Regulation of TP53 Expression and Degradation	17	0.196319831842041	1	4	13	986	6210	1.71431966726084
R-HSA-6806667	Metabolism of fat-soluble vitamins	20	1	1	0	20	990	6203	0
R-HSA-6806834	Signaling by MET	41	0.934059585791378	1	3	38	987	6185	0.533111603843311
R-HSA-6807004	Negative regulation of MET activity	10	0.408112251490243	1	2	8	988	6215	1.45717171717172
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	28	0.759860774933017	1	3	25	987	6198	0.780627705627706
R-HSA-6807878	COPI-mediated anterograde transport	41	0.934059585791378	1	3	38	987	6185	0.533111603843311
R-HSA-6809371	Formation of the cornified envelope	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	37	0.971064128807228	1	2	35	988	6188	0.393830193830194
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	24	0.0374824123434994	0.886302875205662	7	17	983	6206	2.12504208754209
R-HSA-6811438	Intra-Golgi traffic	24	0.423015473847117	1	4	20	986	6203	1.21430976430976
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	32	0.139673971391194	1	7	25	983	6198	1.59378156565657
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	93	0.290476239623247	1	15	78	975	6145	1.17513848159009
R-HSA-6811555	PI5P Regulates TP53 Acetylation	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	43	0.23048564856537	1	8	35	982	6188	1.35550857411323
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	19	0.75699721466733	1	2	17	988	6206	0.766932482721956
R-HSA-68689	CDC6 association with the ORC:origin complex	 5	1	1	0	5	990	6218	0
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	21	0.804927980420863	1	2	19	988	6204	0.693891293891294
R-HSA-68867	Assembly of the pre-replicative complex	22	0.82558867547774	1	2	20	988	6203	0.662350780532599
R-HSA-68874	M/G1 Transition	27	0.902081645502541	1	2	25	988	6198	0.539693228582117
R-HSA-68875	Mitotic Prophase	49	0.681281260046283	1	6	43	984	6180	0.892145949288806
R-HSA-68877	Mitotic Prometaphase	48	0.113451565158822	1	10	38	980	6185	1.51788720538721
R-HSA-68882	Mitotic Anaphase	72	0.279341283570018	1	12	60	978	6163	1.21430976430976
R-HSA-68884	Mitotic Telophase/Cytokinesis	 9	0.114602333995133	1	3	6	987	6217	2.42861952861953
R-HSA-68949	Orc1 removal from chromatin	23	0.844259384311082	1	2	21	988	6202	0.633552920509442
R-HSA-68962	Activation of the pre-replicative complex	11	1	1	0	11	990	6212	0
R-HSA-69002	DNA Replication Pre-Initiation	27	0.902081645502541	1	2	25	988	6198	0.539693228582117
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	15	0.630455364546741	1	2	13	988	6210	0.971447811447812
R-HSA-69052	Switching of origins to a post-replicative state	23	0.844259384311082	1	2	21	988	6202	0.633552920509442
R-HSA-69091	Polymerase switching	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-69109	Leading Strand Synthesis	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-69186	Lagging Strand Synthesis	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-69190	DNA strand elongation	10	0.408112251490243	1	2	8	988	6215	1.45717171717172
R-HSA-69202	Cyclin E associated events during G1/S transition 	25	0.11766746793203	1	6	19	984	6204	1.74860606060606
R-HSA-69205	G1/S-Specific Transcription	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-69206	G1/S Transition	42	0.211091717116274	1	8	34	982	6189	1.38778258778259
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	16	0.379822452259589	1	3	13	987	6210	1.36609848484848
R-HSA-69231	Cyclin D associated events in G1	15	0.0442441512281394	0.887479435526579	5	10	985	6213	2.42861952861953
R-HSA-69236	G1 Phase	15	0.0442441512281394	0.887479435526579	5	10	985	6213	2.42861952861953
R-HSA-69239	Synthesis of DNA	32	0.657725837089683	1	4	28	986	6195	0.910732323232323
R-HSA-69242	S Phase	47	0.18791386766255	1	9	38	981	6185	1.39516441005803
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	 7	0.247976182965643	1	2	5	988	6218	2.08167388167388
R-HSA-69275	G2/M Transition	78	0.382438756476631	1	12	66	978	6157	1.12090132090132
R-HSA-69298	Association of licensing factors with the pre-replicative complex	 6	1	1	0	6	990	6217	0
R-HSA-69300	Removal of licensing factors from origins	24	0.861096544079959	1	2	22	988	6201	0.607154882154882
R-HSA-69304	Regulation of DNA replication	24	0.861096544079959	1	2	22	988	6201	0.607154882154882
R-HSA-69306	DNA Replication	34	0.705239194544364	1	4	30	986	6193	0.857159833630422
R-HSA-69473	G2/M DNA damage checkpoint	36	0.561913652843832	1	5	31	985	6192	1.01192480359147
R-HSA-69481	G2/M Checkpoints	58	0.700714531180928	1	7	51	983	6172	0.879327760362243
R-HSA-69541	Stabilization of p53	18	0.729410310614807	1	2	16	988	6207	0.809539842873176
R-HSA-69563	p53-Dependent G1 DNA Damage Response	22	0.82558867547774	1	2	20	988	6203	0.662350780532599
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	22	0.82558867547774	1	2	20	988	6203	0.662350780532599
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	16	0.666260066302048	1	2	14	988	6209	0.910732323232323
R-HSA-69610	p53-Independent DNA Damage Response	16	0.666260066302048	1	2	14	988	6209	0.910732323232323
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	16	0.666260066302048	1	2	14	988	6209	0.910732323232323
R-HSA-69615	G1/S DNA Damage Checkpoints	22	0.82558867547774	1	2	20	988	6203	0.662350780532599
R-HSA-69618	Mitotic Spindle Checkpoint	11	0.803122911123218	1	1	10	989	6213	0.662350780532599
R-HSA-69620	Cell Cycle Checkpoints	75	0.826222380963147	1	8	67	982	6156	0.777158249158249
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	23	0.19972658405424	1	5	18	985	6205	1.58388230127361
R-HSA-70153	Glucose transport	21	0.804927980420863	1	2	19	988	6204	0.693891293891294
R-HSA-70171	Glycolysis	18	0.226882351376564	1	4	14	986	6209	1.61907968574635
R-HSA-70221	Glycogen breakdown (glycogenolysis)	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-70263	Gluconeogenesis	16	0.167154439514807	1	4	12	986	6211	1.82146464646465
R-HSA-70268	Pyruvate metabolism	16	0.167154439514807	1	4	12	986	6211	1.82146464646465
R-HSA-70326	Glucose metabolism	38	0.14082594142862	1	8	30	982	6193	1.53386496544391
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	17	0.196319831842041	1	4	13	986	6210	1.71431966726084
R-HSA-70895	Branched-chain amino acid catabolism	16	0.379822452259589	1	3	13	987	6210	1.36609848484848
R-HSA-71064	Lysine catabolism	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-71403	Citric acid cycle (TCA cycle)	13	0.0910686735197566	1	4	9	986	6214	2.24180264180264
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	30	0.044569451828207	0.887479435526579	8	22	982	6201	1.94289562289562
R-HSA-72086	mRNA Capping	13	0.0239430591208336	0.754871447281836	5	8	985	6215	2.8022533022533
R-HSA-72163	mRNA Splicing - Major Pathway	74	0.00972285249885099	0.58784701232512	18	56	972	6167	1.77223587223587
R-HSA-72165	mRNA Splicing - Minor Pathway	18	0.226882351376564	1	4	14	986	6209	1.61907968574635
R-HSA-72172	mRNA Splicing	77	0.00682904270172905	0.516730897764165	19	58	971	6165	1.79780926144563
R-HSA-72187	mRNA 3'-end processing	27	0.0668965698886853	1	7	20	983	6203	1.88892630003741
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	39	0.450198473401003	1	6	33	984	6190	1.12090132090132
R-HSA-72306	tRNA processing	47	0.101641133670357	1	10	37	980	6186	1.55018267784225
R-HSA-72312	rRNA processing	37	0.8998484303677	1	3	34	987	6189	0.590745290745291
R-HSA-72613	Eukaryotic Translation Initiation	18	0.930105734940293	1	1	17	989	6206	0.404769921436588
R-HSA-72649	Translation initiation complex formation	12	0.830185993320943	1	1	11	989	6212	0.607154882154882
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	12	0.830185993320943	1	1	11	989	6212	0.607154882154882
R-HSA-72689	Formation of a pool of free 40S subunits	13	0.853532176713842	1	1	12	989	6211	0.56045066045066
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	11	0.803122911123218	1	1	10	989	6213	0.662350780532599
R-HSA-72702	Ribosomal scanning and start codon recognition	13	0.853532176713842	1	1	12	989	6211	0.56045066045066
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	17	0.918955989144433	1	1	16	989	6207	0.428579916815211
R-HSA-72737	Cap-dependent Translation Initiation	18	0.930105734940293	1	1	17	989	6206	0.404769921436588
R-HSA-72764	Eukaryotic Translation Termination	 8	1	1	0	8	990	6215	0
R-HSA-72766	Translation	34	0.705239194544364	1	4	30	986	6193	0.857159833630422
R-HSA-727802	Transport of nucleotide sugars	 5	1	1	0	5	990	6218	0
R-HSA-73728	RNA Polymerase I Promoter Opening	12	1	1	0	12	990	6211	0
R-HSA-73762	RNA Polymerase I Transcription Initiation	21	0.00475463416739118	0.385464984284928	8	13	982	6210	2.77556517556518
R-HSA-73772	RNA Polymerase I Promoter Escape	13	0.000724135686275365	0.0913215559913932	7	6	983	6217	3.92315462315462
R-HSA-73776	RNA Polymerase II Promoter Escape	17	0.0723669144512981	1	5	12	985	6211	2.14289958407605
R-HSA-73777	RNA Polymerase I Chain Elongation	24	0.0374824123434994	0.886302875205662	7	17	983	6206	2.12504208754209
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	17	0.0723669144512981	1	5	12	985	6211	2.14289958407605
R-HSA-73780	RNA Polymerase III Chain Elongation	10	0.408112251490243	1	2	8	988	6215	1.45717171717172
R-HSA-73847	Purine metabolism	13	0.550031792606154	1	2	11	988	6212	1.12090132090132
R-HSA-73848	Pyrimidine metabolism	 8	1	1	0	8	990	6215	0
R-HSA-73854	RNA Polymerase I Promoter Clearance	33	0.0732071670047942	1	8	25	982	6198	1.76626874808693
R-HSA-73856	RNA Polymerase II Transcription Termination	29	0.0369711937350509	0.886302875205662	8	21	982	6202	2.00989202368513
R-HSA-73857	RNA Polymerase II Transcription	57	0.0083393556608466	0.58784701232512	15	42	975	6181	1.91733120680489
R-HSA-73863	RNA Polymerase I Transcription Termination	14	0.000170628677890598	0.0645545164686096	8	6	982	6217	4.16334776334776
R-HSA-73864	RNA Polymerase I Transcription	33	0.0732071670047942	1	8	25	982	6198	1.76626874808693
R-HSA-73884	Base Excision Repair	13	0.26011368582975	1	3	10	987	6213	1.68135198135198
R-HSA-73886	Chromosome Maintenance	26	0.280666686955417	1	5	21	985	6202	1.40112665112665
R-HSA-73887	Death Receptor Signalling	26	0.712856044668516	1	3	23	987	6200	0.840675990675991
R-HSA-73893	DNA Damage Bypass	20	0.782117548004133	1	2	18	988	6205	0.728585858585859
R-HSA-73923	Lipid digestion, mobilization, and transport	41	0.982535818677347	1	2	39	988	6184	0.355407735895541
R-HSA-73933	Resolution of Abasic Sites (AP sites)	13	0.26011368582975	1	3	10	987	6213	1.68135198135198
R-HSA-73980	RNA Polymerase III Transcription Termination	15	0.339947199869943	1	3	12	987	6211	1.45717171717172
R-HSA-74158	RNA Polymerase III Transcription	19	0.108198254496181	1	5	14	985	6209	1.91733120680489
R-HSA-74182	Ketone body metabolism	 6	0.193933493835446	1	2	4	988	6219	2.42861952861953
R-HSA-74217	Purine salvage	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-74749	Signal attenuation	 6	0.193933493835446	1	2	4	988	6219	2.42861952861953
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	19	0.108198254496181	1	5	14	985	6209	1.91733120680489
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	12	0.070414638320088	1	4	8	986	6215	2.42861952861953
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	26	0.000330390951524875	0.0749987459961466	11	15	979	6208	3.08247863247863
R-HSA-75109	Triglyceride Biosynthesis	32	0.000668563021986621	0.0913215559913932	12	20	978	6203	2.73219696969697
R-HSA-75153	Apoptotic execution  phase	27	0.518185379219424	1	4	23	986	6200	1.07938645716423
R-HSA-75205	Dissolution of Fibrin Clot	 5	1	1	0	5	990	6218	0
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	16	0.379822452259589	1	3	13	987	6210	1.36609848484848
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	16	0.00331760424007526	0.342316437498674	7	9	983	6214	3.18756313131313
R-HSA-75892	Platelet Adhesion to exposed collagen	 7	1	1	0	7	990	6216	0
R-HSA-75893	TNF signaling	22	0.59832102985209	1	3	19	987	6204	0.993526170798898
R-HSA-75953	RNA Polymerase II Transcription Initiation	17	0.0723669144512981	1	5	12	985	6211	2.14289958407605
R-HSA-75955	RNA Polymerase II Transcription Elongation	22	0.0235739407354913	0.754871447281836	7	15	983	6208	2.3182277318641
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	64	0.889636744568365	1	6	58	984	6165	0.683049242424242
R-HSA-76009	Platelet Aggregation (Plug Formation)	16	0.906029684851375	1	1	15	989	6208	0.455366161616162
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	17	0.0723669144512981	1	5	12	985	6211	2.14289958407605
R-HSA-76046	RNA Polymerase III Transcription Initiation	14	0.114241927290585	1	4	10	986	6213	2.08167388167388
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	13	0.0910686735197566	1	4	9	986	6214	2.24180264180264
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	12	0.221103298373598	1	3	9	987	6214	1.82146464646465
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	12	0.505429006948245	1	2	10	988	6213	1.21430976430976
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	11	0.0108764645452225	0.58784701232512	5	6	985	6217	3.31175390266299
R-HSA-77111	Synthesis of Ketone Bodies	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	11	0.458041388852471	1	2	9	988	6214	1.3247015610652
R-HSA-77387	Insulin receptor recycling	15	0.139695664040565	1	4	11	986	6212	1.94289562289562
R-HSA-774815	Nucleosome assembly	15	0.630455364546741	1	2	13	988	6210	0.971447811447812
R-HSA-77595	Processing of Intronless Pre-mRNAs	10	0.147713523591521	1	3	7	987	6216	2.18575757575758
R-HSA-844456	The NLRP3 inflammasome	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-877300	Interferon gamma signaling	40	0.475704440067052	1	6	34	984	6189	1.09287878787879
R-HSA-877312	Regulation of IFNG signaling	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	 6	1	1	0	6	990	6217	0
R-HSA-879518	Transport of organic anions	 5	1	1	0	5	990	6218	0
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-8848021	Signaling by PTK6	33	0.0297230457662815	0.865016844736653	9	24	981	6199	1.9870523415978
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	13	0.0239430591208336	0.754871447281836	5	8	985	6215	2.8022533022533
R-HSA-8849932	SALM protein interactions at the synapses	11	1	1	0	11	990	6212	0
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	 5	1	1	0	5	990	6218	0
R-HSA-8851708	Signaling by FGFR2 IIIa TM	 9	1	1	0	9	990	6214	0
R-HSA-8851805	MET activates RAS signaling	 6	1	1	0	6	990	6217	0
R-HSA-8852135	Protein ubiquitination	25	0.252884001585257	1	5	20	985	6203	1.45717171717172
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	25	0.876251179274085	1	2	23	988	6200	0.582868686868687
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	11	0.803122911123218	1	1	10	989	6213	0.662350780532599
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	19	0.258531443878	1	4	15	986	6208	1.53386496544391
R-HSA-8854214	TBC/RABGAPs	17	0.419144442349064	1	3	14	987	6209	1.28573975044563
R-HSA-8854518	AURKA Activation by TPX2	36	0.889094220186433	1	3	33	987	6190	0.607154882154882
R-HSA-8855121	VLDL interactions	11	0.803122911123218	1	1	10	989	6213	0.662350780532599
R-HSA-8856688	Golgi-to-ER retrograde transport	54	0.319121767139247	1	9	45	981	6178	1.21430976430976
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	59	0.717975177072109	1	7	52	983	6171	0.86442390001712
R-HSA-8856828	Clathrin-mediated endocytosis	83	0.59880246948383	1	11	72	979	6151	0.965595716198126
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-8863678	Neurodegenerative Diseases	 9	0.356032505910499	1	2	7	988	6216	1.61907968574635
R-HSA-8863795	Downregulation of ERBB2 signaling	16	0.379822452259589	1	3	13	987	6210	1.36609848484848
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	19	0.494921626168357	1	3	16	987	6207	1.15039872408293
R-HSA-8866427	VLDLR internalisation and degradation	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	12	0.221103298373598	1	3	9	987	6214	1.82146464646465
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	16	0.379822452259589	1	3	13	987	6210	1.36609848484848
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	 5	1	1	0	5	990	6218	0
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	 5	0.141743208612563	1	2	3	988	6220	2.91434343434343
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-8868773	rRNA processing in the nucleus and cytosol	35	0.962874608738289	1	2	33	988	6190	0.416334776334776
R-HSA-8873719	RAB geranylgeranylation	36	0.372494138794354	1	6	30	984	6193	1.21430976430976
R-HSA-8874081	MET activates PTK2 signaling	16	1	1	0	16	990	6207	0
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	 8	0.693237302815547	1	1	7	989	6216	0.910732323232323
R-HSA-8875555	MET activates RAP1 and RAC1	 5	0.522114872805222	1	1	4	989	6219	1.45717171717172
R-HSA-8875878	MET promotes cell motility	21	0.955172387750551	1	1	20	989	6203	0.346945646945647
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	44	0.0319991386419759	0.886302875205662	11	33	979	6190	1.82146464646465
R-HSA-8876384	Listeria monocytogenes entry into host cells	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-8876725	Protein methylation	 9	0.02507731823369	0.769263680952383	4	5	986	6218	3.23815937149271
R-HSA-888590	GABA synthesis, release, reuptake and degradation	17	0.196319831842041	1	4	13	986	6210	1.71431966726084
R-HSA-8948216	Collagen chain trimerization	18	0.729410310614807	1	2	16	988	6207	0.809539842873176
R-HSA-901032	ER Quality Control Compartment (ERQC)	 8	0.302381356595973	1	2	6	988	6217	1.82146464646465
R-HSA-901042	Calnexin/calreticulin cycle	11	0.18343113336022	1	3	8	987	6215	1.9870523415978
R-HSA-909733	Interferon alpha/beta signaling	38	0.785456064516767	1	4	34	986	6189	0.766932482721956
R-HSA-912446	Meiotic recombination	18	0.930105734940293	1	1	17	989	6206	0.404769921436588
R-HSA-912631	Regulation of signaling by CBL	11	0.803122911123218	1	1	10	989	6213	0.662350780532599
R-HSA-912694	Regulation of IFNA signaling	 8	0.084760662074652	1	3	5	987	6218	2.73219696969697
R-HSA-913531	Interferon Signaling	95	0.55038295607583	1	13	82	977	6141	0.997012227538543
R-HSA-913709	O-linked glycosylation of mucins	14	0.591720942589835	1	2	12	988	6211	1.04083694083694
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	10	1	1	0	10	990	6213	0
R-HSA-917937	Iron uptake and transport	28	0.548265735488286	1	4	24	986	6199	1.04083694083694
R-HSA-917977	Transferrin endocytosis and recycling	18	0.226882351376564	1	4	14	986	6209	1.61907968574635
R-HSA-918233	TRAF3-dependent IRF activation pathway	 6	0.193933493835446	1	2	4	988	6219	2.42861952861953
R-HSA-927802	Nonsense-Mediated Decay (NMD)	19	0.75699721466733	1	2	17	988	6206	0.766932482721956
R-HSA-933541	TRAF6 mediated IRF7 activation	11	0.0524665642083245	0.967801477020447	4	7	986	6216	2.6494031221304
R-HSA-933542	TRAF6 mediated NF-kB activation	11	1	1	0	11	990	6212	0
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	 5	1	1	0	5	990	6218	0
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	19	0.939722874955458	1	1	18	989	6205	0.383466241360978
R-HSA-936837	Ion transport by P-type ATPases	33	0.992430038187424	1	1	32	989	6191	0.220783593510866
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	 7	1	1	0	7	990	6216	0
R-HSA-937039	IRAK1 recruits IKK complex	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-937041	IKK complex recruitment mediated by RIP1	 9	0.735387902428678	1	1	8	989	6215	0.809539842873176
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling 	54	0.19904169308561	1	10	44	980	6179	1.34923307145529
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-948021	Transport to the Golgi and subsequent modification	74	0.951835669263945	1	6	68	984	6155	0.590745290745291
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	 7	0.247976182965643	1	2	5	988	6218	2.08167388167388
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	51	0.153234738400462	1	10	41	980	6182	1.42859972271737
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-975155	MyD88 dependent cascade initiated on endosome	53	0.102167291404952	1	11	42	979	6181	1.51215932914046
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	 7	0.6443803095381	1	1	6	989	6217	1.04083694083694
R-HSA-975298	Ligand-gated ion channel transport	10	1	1	0	10	990	6213	0
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	 6	0.587751148599178	1	1	5	989	6218	1.21430976430976
R-HSA-975634	Retinoid metabolism and transport	18	1	1	0	18	990	6205	0
R-HSA-975871	MyD88 cascade initiated on plasma membrane	48	0.0567614940141887	0.967801477020447	11	37	979	6186	1.66967592592593
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	10	1	1	0	10	990	6213	0
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	19	0.75699721466733	1	2	17	988	6206	0.766932482721956
R-HSA-977225	Amyloid fiber formation	25	0.876251179274085	1	2	23	988	6200	0.582868686868687
R-HSA-977441	GABA A receptor activation	 9	1	1	0	9	990	6214	0
R-HSA-977443	GABA receptor activation	30	1	1	0	30	990	6193	0
R-HSA-977444	GABA B receptor activation	21	1	1	0	21	990	6202	0
R-HSA-977606	Regulation of Complement cascade	 9	1	1	0	9	990	6214	0
R-HSA-982772	Growth hormone receptor signaling	11	0.458041388852471	1	2	9	988	6214	1.3247015610652
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	14	0.873671502415689	1	1	13	989	6210	0.52041847041847
R-HSA-983189	Kinesins	25	1	1	0	25	990	6198	0
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	68	0.600716693452933	1	9	59	981	6164	0.964304812834225
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	20	0.128802719985544	1	5	15	985	6208	1.82146464646465
R-HSA-983712	Ion channel transport	95	0.982138367538111	1	7	88	983	6135	0.536852737905369
R-HSA-991365	Activation of GABAB receptors	21	1	1	0	21	990	6202	0
R-HSA-997269	Inhibition of adenylate cyclase pathway	 8	1	1	0	8	990	6215	0
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	13	1	1	0	13	990	6210	0
